Abstract
Introduction:
Liver diseases represent a significant global health challenge, with primary causes including excessive alcohol consumption, infections, chemotherapy, and autoimmune disorders. Medicinal plants, due to their natural bioactive compounds, hold promise for developing effective treatments and preventive measures against liver ailments. This study aimed to document the use of herbal remedies in northeastern Morocco for liver diseases and correlate these uses with scientific evidence through a bibliometric analysis.
Methods:
An ethnobotanical survey was conducted in remote communities of northeastern Morocco from October 2020 to January 2022. A total of 189 informants were interviewed using semi-structured questionnaires to gather information on local medicinal plants used for liver ailments. The data were analyzed using four ethnobotanical quantitative indices: use value (UV), familial use value (FUV), informant consensus factor (ICF), and fidelity level (FL). Additionally, a bibliometric analysis was performed to evaluate the scientific support for the ethnopharmacological uses documented.
Results:
The survey identified 45 plant species from 26 different families used in the treatment of liver diseases. The most frequently utilized species were Cuminum cyminum L. (UV = 0.1065), Allium sativum L. (UV = 0.1015), Salvia officinalis L. (UV = 0.0761), Asparagus officinalis L. (UV = 0.0558), and Ziziphus lotus (L.) Lam. (UV = 0.0457). The Apiaceae family showed the highest familial use value (FUV = 0.1066), followed by Alliaceae (FUV = 0.1015). Liver congestion had the highest informant consensus factor (ICF = 0.83), followed by hepatic colic (ICF = 0.80). Bibliometric analysis revealed that 61% of the plants identified had documented pharmacological effects related to liver health.
Discussion:
The study demonstrates that traditional knowledge in northeastern Morocco encompasses a rich diversity of medicinal plants used to treat liver diseases. The high ICF values indicate a strong consensus among informants on the efficacy of these remedies. The correlation between ethnopharmacological use and scientific validation for a significant portion of these plants suggests their potential as reliable therapeutic agents for liver conditions. However, further scientific investigations are necessary to confirm their efficacy and safety in clinical settings. This research contributes valuable information for future studies on the therapeutic potential of these plants.
Conclusion:
This ethnobotanical survey provides a comprehensive database of medicinal plants used in northeastern Morocco for liver diseases. The findings highlight the potential of these plants in developing novel treatments for hepatic conditions, although further research is essential to substantiate their therapeutic claims.
1 Introduction
The liver is one of the most critical organs in the human body, playing a pivotal role in several physiological functions, including the regulation of metabolic processes, maintenance of blood sugar levels, bile production, and detoxification of foods, water, drugs, and xenobiotics (Marcellin and Kutala, 2018). These functions are vital for sustaining overall health, as the liver processes everything that enters the body, ensuring that nutrients are metabolized correctly and harmful substances are neutralized. Given its extensive involvement in maintaining homeostasis, the liver is susceptible to various diseases, which can manifest as serious clinical syndromes such as jaundice, hepatitis, hepatocarcinoma, and cirrhosis. Because of its essential functions, the liver is often considered a reflection of an individual’s overall health (Rinder et al., 2011).
Liver dysfunction is a significant global health problem, with a variety of causes that contribute to its widespread prevalence. These causes include excessive alcohol consumption, infections (notably viral hepatitis), the use of chemotherapeutic agents, exposure to toxic chemicals, and autoimmune disorders (Wei et al., 2022). The impact of liver diseases is profound, with global mortality rates reaching approximately 2 million deaths annually. Of these, 1 million deaths are attributed to complications arising from viral hepatitis and hepatocellular carcinoma, while another 1 million result from cirrhosis (Asrani et al., 2019). The growing burden of liver diseases has underscored the urgent need for effective therapeutic strategies, particularly in regions where access to conventional medical treatments is limited.
Medicinal plants have long been recognized as a valuable source of therapeutic agents, offering potential remedies for a wide array of health conditions, including liver diseases (Bhagawan et al., 2023a). The use of plants in traditional medicine is deeply rooted in human history, with ethnobotanical practices providing insights into natural remedies that have been utilized for centuries (Bhagawan et al., 2022; 2023b; 2024). In Morocco, traditional herbal medicine remains a cornerstone of healthcare, especially in rural and underserved areas. Recent ethnobotanical research indicates that a significant proportion of the Moroccan population—ranging from 60% to 80%—relies on medicinal plants to meet their healthcare needs (Jamila and Mostafa, 2014; Labiad et al., 2020; Alami Merrouni et al., 2021; Fakchich and Elachouri, 2021; Bencheikh et al., 2022; 2023). This reliance is driven by several factors, including the high cost of conventional medications, limited access to adequate healthcare facilities, and socio-economic challenges, particularly in remote and underdeveloped regions (Bencheikh et al., 2021e; Fakchich and Elachouri, 2021).
The cultural heritage of North-Eastern Morocco, like that of other regions in the country, is steeped in a rich tradition of herbal medicine that dates back to the Arab influence in the 7th century. Over centuries, the indigenous population has developed and maintained extensive knowledge of medicinal plants, which forms the foundation of the region’s traditional medical system. This knowledge is passed down orally from one generation to the next, ensuring the continuity of these traditional practices. However, this oral transmission is also a source of vulnerability. The absence of formal documentation and the lack of ethnobotanical archives pose significant threats to the preservation of this cultural heritage. As modern influences encroach and younger generations turn to contemporary medicine, there is a real risk that this indigenous medicinal knowledge, along with the phytogenetic resources it depends on, could be lost (Eddouks et al., 2017).
In Morocco, despite the widespread use of traditional medicine, there is a notable gap in ethnobotanical documentation, particularly concerning medicinal plants used for treating liver diseases. This lack of documented evidence limits the potential for scientific validation and integration of these traditional practices into modern healthcare systems. To address this gap, we propose a study aimed at documenting and analyzing the traditional knowledge related to medicinal plants used in rural areas of North-East Morocco for the treatment of liver diseases. The study will also seek to correlate these traditional uses with scientific evidence through a bibliometric review, thereby providing a comprehensive understanding of the therapeutic potential of these plants and contributing to the preservation of Morocco’s ethnobotanical heritage.
2 Materials and methods
2.1 Study area
The Eastern region of Morocco, covers 90,130 km2, or 12% of the country’s total size (Figure 1). This region is limited to the West by the provinces of Al Hoceima, Taza, Boulmane, and Errachidia, to the North by the Mediterranean, to the East, and to the South by the Morocco-Algerian border. The population of this region reached 2,314,346 people (6.8% of the total population), with a density of 26 people per square kilometer, according to the national census report issued in 2014 (RGPH, 2014). According to the High Commission for Planning’s survey, the dialect of Arabic was spoken here the most frequently, followed by Berber or Tamazight, which is split into two tiny dialects: Tarifit in the north and tachelhit in the south. The territory’s southern zone is characterized by the vast Highlands and Sahara, while the mountainous areas of Beni Snassen, Rif, and Horst reach 1800 m, 1,500 m, and 1,100 m, respectively, elevations. The region also has 200 km of Mediterranean coastline. With hot, dry summers and cooler, humid winters, the region has a Mediterranean climate zone, with average annual rainfall ranging from 100 mm in the south to 400 mm in the north. Additionally, the area has a number of protected areas and sites of biological and ecological interest, including Al Hoceima National Park, Benisnassen, Jbel Gorougou, Cap des Trois Fourches, Chekhar, Lalla Chafia, and Lalla Mimouna. In fact, these places had already been chosen because of their biological and ecological characteristics as well as their indigenous flora (Fennane, 2004; Fakchich and Elachouri, 2021).
FIGURE 1
2.2 Ethnobotanical data collection
The collection of ethnobotanical data on liver diseases was conducted between October 2020 and January 2022 across twelve rural communes located in five provinces of northeastern Morocco. Traditional knowledge was randomly selected from twelve stations studied through structured and semi-structured interviews using a questionnaire sheet with 189 local residents and 8 traditional herbalists participated. Verbal informed consent was gained from informants following verbal explanation of the study aims. The established best practice for ethnobotanical investigations, the International Society of Ethnobiology’s Code of Ethics, was followed when conducting interviews (International Society of Ethnobiology, 2006). The questionnaire sheet utilized in this study has two sections: the first lists the respondents’ demographic information, and the second lists their floristic and ethnic backgrounds.
2.3 Identification of specimens
We were able to transform the common names of plants identified during our ethnobotanical survey into their botanical names using some relevant references (Bellakhdar et al., 1991; Jamila and Mostafa, 2014). Subsequently, plant samples were collected from various vegetation sites across the northeastern region of Morocco. After the harvest, the botanical identification of the samples was carried out in the Laboratory of Bioresources, Biotechnologies, Ethnopharmacology and Health of the Faculty of Sciences of Mohammed first University, Oujda, Morocco, with the help of available herbaria and a number of essential references such as the catalogue of Moroccan plants and the practical flora of Morocco (Jahandiez and Maire, 1931; 1932; 1934; Fennane et al., 1999; 2007; 2014). After the samples were identified, specimens were placed in the Mohammed First University Herbarium in Oujda, Morocco. Using the World Flora Online (WFO) Plants database (https://wfoplantlist.org/), all scientific names were reviewed once more. Additionally, a group of flowering plants (angiosperms) known as Angiosperm Phylogeny Group III - 2009 has been given credit for naming all plant families (A.P.G III, 2009).
2.4 Quantitative data analysis
To quantify the ethnobotanical information, we adopted a quantitative analysis using ethnobotanical indices such as the Medicinal Use Value (UV), the Family Use Value (FUV), Informant Consensus Factor (ICF), and the Fidelity Level (FL).
• Medicinal use value (UV)
We analyzed the medicinal use value of each plant species to identify the relative relevance of each plant species that is locally recognized to be utilized in herbal treatments. This index is calculated using the formula below (Tabuti et al., 2003):
Where;
: medicinal use value,
U:number of citations per species,
N:number of informants. The UV value will be larger if a plant has a high utilization ratio, indicating that the plant is significant, however if there are few utilization ratios, it will be near to zero.
• Botanical Family Use Value (FUV)
We used the family use value index to analyze the association between botanical families and users of taxa that correspond to these families. This index is equal to the mean total use value of each species in the family (Hoffman and Gallaher, 2007).
Where;
FUV is the family use value, UV is the utility value of the family's species, and N is the number 173 of species in the family.
• Informant Consensus Factor (ICF).
The ICF demonstrates the uniformity of traditional knowledge exchange amongst informants regarding the usage of plants to cure different types of diseases. The following formula was used to determine ICF (Bencheikh et al., 2021e).
Where;
Nur denotes the number of use-reports for an ailment category and Nt denotes the total number of plants used by all informants for that illnesses category. The ICF values range between 0 and 1, with values close to 0 indicating that the herbs were picked at random or that there was no exchange of information about plant usage within the population. Furthermore, ICF values close to 1 indicate a clear selection of medical species and information sharing about their use in the population.
• Fidelity Level (FL).
The level of fidelity (FL) identifies a plant species’ ability to effectively combat a certain disease. FL was determined using the formula below (Sreekeesoon and Mahomoodally, 2014).
Where;
Lu denotes the total number of interviewers who cited all uses of the particular species for the therapies of all liver pathologies, and Ip represents the number of individuals who used a particular species for a specific type of liver disease.
2.5 Pharmacological validation
A bibliographic search was conducted to identify the biological activities of identified plants against liver disease, by the mean of the following databases: PubMed, Science Direct, Google Scholar, Scopus and Web of Science with keywords like “liver disease,” “liver disease,” “Liver failure,” “hepatitis,” “Jaundice,” and “Hepatoprotective” combined with the scientific name of each plant.
3 Results and discussions
3.1 Informants’ sociodemographic profile
A total of 197 informants, including 189 non-specialists and 8 herbalists interviewed for this study. These interviewees are spread over twelve rural stations in five provinces of North-East Morocco (Table 1). The socio-demographic profile of the participants in this study (The variable comprising age, sex, education level, income and attitude towards drugs) were grouped in the Table 2. Analysis of the data presented in Table 2 shows that Women had the highest share of participants (59%), followed by men (40.6%). The use of medicinal plants for the treatment of liver disease in the study areas is widespread in all age groups. The 46–65 age group is the most represented in this study with a frequency of 58.88%, followed by the 25–45 age group with a percentage of 25.38%, the over-65 age group with 14.21%, and the under-25 age group with a percentage of 1.52%. The results of numerous research have consistently shown that older people had more traditional knowledge on how to use medicinal herbs than did younger people (Alami Merrouni et al., 2021; Bencheikh et al., 2021e; Hachlafi et al., 2022). The discomfort of the younger generation, which tends not to accept popular medicine due to the effect of exotic culture, and the influence of lifestyle modernization can be used to explain the gradual loss of traditional knowledge about medicinal plants (Sargin et al., 2015). The fact that there were fewer informants over the age of 65 (14.21%) is a reflection of the depth of traditional knowledge being lost as rural elders pass away.
TABLE 1
| Provinces | Stations | Number of informants | |
|---|---|---|---|
| Local residents | Herbalist | ||
| Guercif | Ras Laksar | 10 | 0 |
| Saka | 11 | 1 | |
| Jal | 16 | 0 | |
| Jerada | Ain Benimathar | 18 | 0 |
| Guenfouda | 10 | 2 | |
| Berkane | Tafoughalt | 11 | 2 |
| Ahfir | 25 | 0 | |
| Nador | Tiztoutine | 10 | 0 |
| Bouarg | 12 | 1 | |
| Oujda-Angad | Bni Drar | 31 | 2 |
| Naima | 19 | 0 | |
| Sidi Moussa Lemhaya | 16 | 0 | |
| Total | 12 stations | 189 | 8 |
Number of informants for each locality.
TABLE 2
| Distribution | Categories | Informants number | Percentage of informants |
|---|---|---|---|
| % | |||
| By sex (197) | Men | 80 | 40.6 |
| Women | 117 | 59.4 | |
| By age range | Less than 25 years | 3 | 1.52 |
| 25–45 | 50 | 25.38 | |
| 46–65 | 116 | 58.88 | |
| More than 65 years | 28 | 14.21 | |
| By education level | Illitirate | 75 | 38.07 |
| Primary education | 69 | 35.03 | |
| Secondary education | 38 | 19.29 | |
| University education | 15 | 7.61 | |
| By income/month | Unemployed | 81 | 41.11 |
| 500–2000 DH | 89 | 45.17 | |
| 2000–6000 DH | 12 | 6.1 | |
| >6000 DH | 15 | 7.61 | |
| By choice of medicine | Herbal medicine | 101 | 51.27 |
| Both conventional and herbal medicine | 76 | 38.58 | |
| Modern medicine | 20 | 10.15 |
Socio-demographic characteristics of informants.
In terms of educational attainment, the findings revealed that 38.07% of the informants are illiterate, followed by the categories of secondary and primary education, with percentages, respectively 35.03% and 19.29%, and lastly the university level, with a percentage of 7.61%. These findings are consistent with those of other ethnobotanical studies conducted in various regions of Morocco (Khouchlaa et al., 2017b; Bencheikh et al., 2021e; Hachlafi et al., 2022). The study area’s rising illiteracy rate may be caused by the fact that poverty is still pervasive in the rural areas examined. This is indicated in our results, where the majority of respondents had a low socio-economic level (41.11% unemployed, and 45.17% between 500 and 2000 DH/month).
There are differences in how the people in this area feel about treating liver illness. The results shown in Table 2 demonstrate the extreme variety of usage patterns. In fact, the majority of interviews indicated that traditional medicine was their first choice of treatment when they were ill, with a percentage of 51.27%, followed by the use of conventional and herbal medicine in second place, with a percentage of 38.58%, and exclusively modern medicine in third place, with a percentage of 10.15%. Access to modern medication is hampered by a lack of health facilities and trained medical personnel, a lack of infrastructure, particularly paved roads, a lack of transportation options, a lack of logistical support, and the high expense of treating liver disease with modern medicine (El Hassani et al., 2013; Eddouks et al., 2017). The aforementioned factors all strongly encourage rural populations to switch to traditional healthcare, especially the usage of medicinal herbs.
3.2 Diversity of plant species used to treat liver diseases
This study recorded the use of 45 medicinal plants, spread across 26 families and 43 genera, for the treatment of liver disease in the study area. Traditional information on the applications of these plants has been developed (Table 3), including the use value, scientific name, botanical family, popular names, traditional uses, parts utilized, preparation procedure, and mode of administration for each medicinal species.
TABLE 3
| Botanical family Scientific name (voucher number) | Local name | Therapeutic uses | Part used | Mode of preparation | Mode of administration | UV |
|---|---|---|---|---|---|---|
| ASTERACEAE Artemisia absinthum L. (HUMPOM903) | Chiba - lahyat cheikh | Hepatic colic, hepatitis, detoxification, jaundice | Leaves | Decoction | Oral | 0.0355 |
| Artemisia herba-alba Asso. (HUMPOM923) | Izri - halfa | Detoxification | Leaves | Decoction | Oral | 0.0051 |
| Cynara scolymus L. (HUMPOM924) | Khorchef | Liver diseases, hepatic colic | Stems, flowers | Infusion | Oral | 0.0203 |
| Anacyclus pyrethrum (L.) Lag. (HUMPOM925) | Oud alatass | Liver diseases | Stems | Decoction | Oral | 0.0051 |
| Reichardia intermedia (Sch.Bip.) Samp. (HUMPOM926) | Nokad | Hepatic colic, liver congestion | Leaves | Decoction | Oral | 0.0152 |
| ALLIACEAE Allium sativum L. (HUMPOM927) | Thouma | Liver cancer, hepatoprotective effect, liver diseases, hepatitis | Bulb, leaves | Decoction, infusion, in food, maceration | Oral | 0.1015 |
| ANACARDIACEAE Pistacia lentiscus L. (HUMPOM895) | Dro - btam | Liver cancer, liver diseases, hepatic colic | Fruit, leaves | Decoction | Oral | 0.0305 |
| APIACEAE Cuminum cyminum L. (HUMPOM909) | Kamoun | Detoxification, liver diseases, jaundice, hepatitis | Seed | Decoction, infusion, powder | Oral | 0.1065 |
| Apium nodiflorum (L.) Lag. (HUMPOM928) | Zyata | Liver diseases, hepatic colic, bile problems | Leaves | Decoction | Oral | 0.0254 |
| Pimpinella anisum L. (HUMPOM902) | Habat hlawa - yanssoun | Hepatitis, hepatitis | Leaves, fruit | Decoction, powder, infusion | Oral | 0.0152 |
| Coriandrum sativum L. (HUMPOM910) | Kossber | Liver diseases | Leaves | Decoction | Oral | 0.0051 |
| APOCYNACEAE Nerium oleander L. (HUMPOM901) | Alili, defla | Liver diseases, liver cancer | Leaves | Decoction | Oral | 0.0102 |
| ARECACEAE Cocos nucifera L. (HUMPOM911) | Noix de coco | Jaundice | Fruit | - | Oral | 0.0051 |
| ASPARAGACEAE Asparagus officinalis L. (HUMPOM898) | Sekoum | Bile problems, liver stones, hepatitis, jaundice | Stems, leaves | Decoction, infusion, in food | Oral | 0.0558 |
| COMBRETACEAE Terminalia arjuna (Roxb. ex DC.) Wight and Arn. (HUMPOM915) | Aarjouna | Hepatic colic | Leaves | Decoction | Oral | 0.0051 |
| FABACEAE Lupinus albus L. (HUMPOM929) | Termass | Hepatitis, liver diseases | Fruit, leaves | Decoction, infusion | Oral | 0.0254 |
| Ceratonia siliqua L. (HUMPOM931) | Kharoub | Liver diseases, jaundice | Fruit | Maceration, infusion | Oral | 0.0102 |
| Glycyrrhiza glabra L. (HUMPOM930) | Arq souss | Liver diseases | Stems | Infusion | Oral | 0.0051 |
| PLANTAGINACEAE Globularia alypum L. (HUMPOM894) | Tasselgha | Liver diseases, hepatitis | Fruit, leaves, whole plant | Decoction | Oral | 0.0203 |
| IRIDACEAE Crocus sativus L. (HUMPOM912) | Zaafran lhor | Liver diseases | Flowers | Decoction | Oral | 0.0051 |
| LAMIACEAE Salvia officinalis L. (HUMPOM904) | Salmiya | Jaundice, liver diseases, hepatitis, liver cancer, detoxification | Leaves, stems | Decoction, infusion | Oral | 0.0761 |
| Thymus vulgaris L. (HUMPOM932) | Zaatar | Hepatoprotective effect, liver diseases, hepatic colic | Leaves | Decoction | Oral | 0.0355 |
| Ocimum basilicum L. (HUMPOM916) | Rihane - hbek | Liver diseases, jaundice, hepatitis | Leaves | Decoction, infusion | Oral | 0.0355 |
| Rosmarinus officinalis L. (HUMPOM919) | Azir - yazir | Hepatitis, detoxification, liver diseases | Leaves | Decoction | Oral | 0.0254 |
| Lavandula dentata L. (HUMPOM920) | Khzama | Liver diseases, hepatitis | Flowers, leaves | Decoction, infusion | Oral | 0.0203 |
| Mentha pulegium L. (HUMPOM921) | Fliyo | Hepatitis, jaundice | Leaves | Decoction | Oral | 0.0152 |
| Mentha spicata L. (HUMPOM913) | Naanaa | Liver diseases | Leaves | Infusion | Oral | 0.0051 |
| LAURACEAE Laurus nobilis L. (HUMPOM922) | Wrak sidna moussa | Hepatitis | Leaves | Infusion | Oral | 0.0051 |
| MALVACEAE Malva parviflora L. (HUMPOM905) | Khoubiza | Liver diseases | Leaves | Decoction | Oral | 0.0051 |
| MYRTACEAE Syzygium aromaticum (L.) Merr. and L.M.Perry (HUMPOM896) | Kronfol | Detoxification, liver diseases | Leaves | Decoction, infusion | Oral | 0.0254 |
| Eucalyptus globulus Labill. (HUMPOM933) | Eucalyptus | Liver diseases | Leaves | Oil | Oral | 0.0051 |
| OLEACEAE Olea europaea L. (HUMPOM908) | Zitoune | Liver diseases | Leaves, fruit | Oil, decoction | Oral | 0.0152 |
| PIPERACEAE Piper nigrum L. (HUMPOM914) | Flfla kehla | Hepatic colic, liver diseases, liver cancer | Fruit | Decoction, poudre infusion | Oral | 0.0355 |
| PLUMBAGINACEAE Armeria alliacea (Cav.) Hoffmanns. and Link (HUMPOM899) | Arq wedmi | Liver diseases, jaundice | Fruit, stems | Infusion, decoction | Oral | 0.0152 |
| POACEAE Zea mays L. (HUMPOM934) | Dorra, kbal | Liver diseases | Cones, fruit | Decoction, infusion | Oral | 0.0102 |
| Hordeum vulgare L. (HUMPOM906) | Chaair | Liver diseases | Leaves | Decoction | Oral | 0.0051 |
| POLYGONACEAE Rumex vesicarius L. (HUMPOM935) | Zriaat lhemida | Detoxification, liver diseases | Seeds, leaves | Infusion, decoction | Oral | 0.0203 |
| RANUNCULACEAE Nigella sativa L. (HUMPOM917) | Haba kahla | Liver cancer, liver diseases | Seeds | Decoction | Oral | 0.0102 |
| RHAMNACEAE Ziziphus lotus (L.) Lam. (HUMPOM918) | Nbeg | Jaundice, liver diseases, hepatic colic, hepatitis | Fruit, leaves | In food, maceration, infusion, decoction | Oral | 0.0457 |
| ROSACEAE Agrimonia repens L. (HUMPOM887) | Makerman | Jaundice, liver diseases | Leaves | Decoction | Oral | 0.0102 |
| Crataegus monogyna Jacq. (HUMPOM936) | Zaarour | Liver diseases | Leaves | Infusion | Oral | 0.0051 |
| RUTACEAE Citrus × aurantium L. (HUMPOM937) | Ranj | Liver diseases, liver congestion | Fruit | Decoction, maceration | Oral | 0.0254 |
| THEACEAE Camellia sinensis (L.) Kuntze (HUMPOM907) | Atay | Liver diseases | Whole plant | Infusion | Oral | 0.0051 |
| ZINGIBERACEAE Zingiber officinale Roscoe (HUMPOM938) | Skinjbir | Liver diseases, hepatic colic, jaundice | Whole plant, rhizomes | Decoction, infusion, powder | Oral | 0.0254 |
| Curcuma longa L. (HUMPOM939) | Kharkoum | Liver diseases, hepatitis | Whole plant | Powder | Oral | 0.0102 |
Medicinal plants used in the study area for the treatment of liver ailments.
Bold indicates the best values.
3.2.1 Frequency of families and their use value
As indicated in Table 4, a total of 26 botanical families were used in rural areas of North-East Morocco for the treatment of liver pathologies. However, the families most used are Lamiaceae (7 species; 6 genera) in the first position, followed by Asteraceae (5 species; 4 genera), Apiaceae (4 species; 4 genera), Fabaceae (3 species; 3 genera), Myrtaceae, Poaceae, Rosaceae and Zingiberaceae with (3 species; 3 genera) for each. There are only one species and one genus for the other families. Similarly, the Lamiaceae, Asteraceae, and Apiaceae botanical families are the ones that are most prevalent in Mediterranean countries (Benítez et al., 2010; Savo et al., 2011). The predominance of the Asteraceae family in the traditional treatment of liver disease has already been confirmed by an ethnobotanical study carried out in the Maritime region of Togo (Kpodar et al., 2016).
TABLE 4
| Family | Number of species | Number of genera | FUV | Family | Number of species | Number of genera | FUV |
|---|---|---|---|---|---|---|---|
| Lamiaceae | 7 | 6 | 0.0305 | Combretaceae | 1 | 1 | 0.0051 |
| Asteraceae | 5 | 4 | 0.0162 | Plantaginaceae | 1 | 1 | 0.0203 |
| Apiaceae | 4 | 4 | 0.1066 | Iridaceae | 1 | 1 | 0.0051 |
| Fabaceae | 3 | 3 | 0.0135 | Lauraceae | 1 | 1 | 0.0051 |
| Myrtaceae | 2 | 2 | 0.0152 | Malvaceae | 1 | 1 | 0.0051 |
| Poaceae | 2 | 2 | 0.0076 | Oleaceae | 1 | 1 | 0.0152 |
| Rosaceae | 2 | 2 | 0.0076 | Piperaceae | 1 | 1 | 0.0355 |
| Zingiberaceae | 2 | 2 | 0.0178 | Plumbaginaceae | 1 | 1 | 0.0152 |
| Alliaceae | 1 | 1 | 0.1015 | Polygonaceae | 1 | 1 | 0.0203 |
| Anacardiaceae | 1 | 1 | 0.0305 | Ranunculaceae | 1 | 1 | 0.0102 |
| Apocynaceae | 1 | 1 | 0.0102 | Rhamnaceae | 1 | 1 | 0.0457 |
| Arecaceae | 1 | 1 | 0.0051 | Rutaceae | 1 | 1 | 0.0254 |
| Asparagaceae | 1 | 1 | 0.0558 | Theaceae | 1 | 1 | 0.0051 |
Distribution of botanical medicinal families according to species and genera. FUV: Family Use Value.
Bold indicates the best values.
Families with high FUV are Apiaceae (0.1066), Alliaceae (0.1015), Asparagaceae (0.0558), and Piperaceae (0.0355) (Table 4). However, there aren't many species in these groups to represent them. It appears that the value of using ethnobotanical families is not dependent on their particular wealth but rather on the significance and value of the use of the individual species (Najem et al., 2019). Additionally, these families’ significant FUV would be mostly dependent on their abundance of bioactive compounds, which would confer multiple benefits such as antimicrobial, anti-allergic, anti-oxidant, and anti-inflammatory properties (Bencheikh et al., 2022).
3.2.2 Most used plants species to treat liver diseases according to use value index
In this work, we inventoried 45 different medicinal plants that are utilized to treat liver ailments in rural areas of North Eastern Morocco. Nevertheless, the most widely used plants for the treatment of liver diseases are Cuminum cyminum L. (UV = 0.1065), followed by Allium sativum L. (UV = 0.1015), Salvia officinalis L. (UV = 0.0761), Asparagus officinalis L. (UV = 0.0558), and Ziziphus lotus (L.) Lam. (UV = 0.0457) (Table 3). These five species made up 27.84% of all use ratios, while the other 40 species only made up 72.16% of all use ratios. Similar studies conducted in other nations have shown that high utilization values have been attained for plants other than those in the current study (Kotoky and Das, 2008; Kpodar et al., 2016). This difference in species similarity could be explained by the difference in bioclimate between countries, which will favor the difference in the abundance of certain plant species from one country to another. In addition, geographic distance between countries has a direct impact on the traditional cultures of indigenous peoples, as evidenced by Alami Merrouni et al. (2021), in which they demonstrated that the increase in distance between countries is accompanied by the increase in the difference in the cultures of these countries and vice versa. Thus, all these factors can lead to differences between countries in the use of plant species to treat a particular health condition.
These five medicinal plants were frequently utilized in traditional Moroccan medicine to cure a wide range of illnesses:
Cuminum cyminum L.: This Apiaceae family medicinal plant was one of the first plants grown in Asia, Africa, and Europe (Al-snafi, 2017). Since antiquity, C. cyminum seeds have persisted in popularity as culinary seasonings and are widely utilized in folk therapy across a variety of geographic regions. This plant, called in Morocco as “Kammun”, is frequently used conventionally to treat digestive system issues, including diarrhea (Jamila and Mostafa, 2014). According to the analysis of the data collected during our investigation, C. cyminum is the most widely used to treat liver pathologies in the North-Eastern Moroccan population with a usage value of 0.1065. Indeed, the seeds of C. cyminum, in decoction or infusion, are used by the study population as treatment of jaundice, and hepatitis, and thus for liver detoxification. In Ayurveda (former Indian therapeutic system), seeds of C. cyminum are traditionally used against jaundice and to improve liver function (Andallu and Ramya, 2007; Johri, 2011).
Allium sativum L.: This plant, called locally as “Thouma” in Morocco, is one of the earliest known to have been cultivated (Thomson and Ali, 2003). Traditional Moroccan medicine makes extensive use of garlic to cure and prevent a wide range of illnesses, including cancer, lung disease, hypertension, diabetes, microbiological infections, infertility, and problems with the kidneys (Fakchich and Elachouri, 2021). According to the results of our investigation, this plant is classified according to its use value in the second position as the plant most used to treat liver diseases in the northeast of Morocco. Indeed, the leaves and bulb of this plant in decoction or infusion are widely recommended by the inhabitants of the study area to fight against liver cancer and hepatitis, and thus declared that it has hepatoprotective effects. Furthermore, it has been reported that portions of this plant are commonly used to heal liver problems in Togo’s Maritime region (Kpodar et al., 2016). The bulb of plant is often used to treat jaundice in the southern region of Algeria (Bendaif et al., 2021).
Salvia officinalis L.: This round perennial shrub belongs to the Lamiaceae family and is called to as “Salmiya” in the Oriental area of Morocco. It is indigenous to the Middle East and the Mediterranean, although it has since become naturalized everywhere (Ghorbani and Esmaeilizadeh, 2017). In Morocco, the aerial part of S. officinalis is used to handle gastrointestinal problems, metabolic disorders, and renal ailment (Bencheikh et al., 2021e; Fakchich and Elachouri, 2021). Based on the findings of the current investigation, this plant is classified among the three most used medicinal species in the study area for the treatment of liver diseases. Indeed, the leaves and stems of S. officinalis, in decoction or infusion are widely used in rural areas of north-eastern Morocco to prevent and treat jaundice, hepatitis, and liver cancer, and thus to detoxify the liver. In the middle Oum Rbia region of Morocco, leaves and whole plant decocted were used for liver problems (Ben Akka et al., 2019). In addition to these local uses, in traditional South-West Algerian medicine, the flowers of this plant were also used to treat liver symptoms (Benarba, 2016).
Asparagus officinalis L.: Since ancient times, asparagus, a perennial herbaceous plant of the Asparagaceae family, has been utilized extensively in food and medicinal. This plant is called « Sekoum» in Morocco, is used to treat various ailments such as respiratory diseases, digestive problems, kidney diseases, liver diseases and diabetes (Alami Merrouni and Elachouri, 2021; Fakchich and Elachouri, 2021; Bencheikh et al., 2022). In our study, asparagus is ranked fourth among the most cited plants for the treatment of liver patients. In fact, this plant’s leaves and stems are frequently used to treat biliary issues, liver stones, hepatitis, and jaundice.
Ziziphus lotus (L.) Lam.: The majority of Africa, numerous Asian nations, including China, Iran, and South Korea, as well as several European nations, including Cyprus, Spain, and Greece, are all home to this medicinal plant (Adeli and Samavati, 2014; Bencheikh et al., 2021d). In Morocco, Z. lotus is locally known as “Sedra,” and “Nbeg” for its fruits, and is widely found in arid and semi-arid areas (Bencheikh et al., 2019). Plant parts were traditionally used to combat various health problems such as sedation, anxiety, urinary problems, diabetes, skin infections, scarring, and bronchitis (Khouchlaa et al., 2017a; Bencheikh et al., 2021e; Fakchich and Elachouri, 2021). As per the findings of our survey, Z. lotus in rural parts of North-East Morocco, is one of the top five plants used to treat liver disorders such as jaundice, hepatic colic, and hepatitis. Furthermore, the fruits of this medicinal plant are traditionally used to treat lung diseases, jaundice, and as an emollient in El Hammadia, Algeria (Bendaif et al., 2021).
3.3 Ethnic medicinal characteristics
In this study, different parts of plants are used as medicines to treat liver problems in rural areas of North-East Morocco (Figure 2). Thus, on the basis of calculating the percentage of use of each part (%), the leaves (50.82) appear to be the most commonly utilized for the treatment of liver illnesses in the study area, followed by fruits (21.3), stems (9.84), whole plants (6.56), the seeds, and the flowers (4.92) for each, and finally the bulbs (1.64). The leaves are both a source of photochemical reactions and a repository of organic stuff created from them, which explains why they are used so frequently (Bencheikh et al., 2021e). In addition, it is important to avoid pulling out the entire plant or picking up the roots of the plants, as this will promote deforestation and put the species at risk (Kadir et al., 2013). On the contrary, the use of leaves contributes to the conservation and sustainable use of the plant.
FIGURE 2
As seen in Figure 3, various techniques are used in rural North-East Morocco to make alternative therapies for treating liver disease. Nevertheless, with a percentage of 48.61%, decoction remains the most commonly employed method of preparation, followed by infusion (29.17%), maceration (6.94%), powder and preparation in the diet (5.56% for each), and finally oils with 4.17%. The preparation technique is frequently correlated with the type of use (external or internal); typically, external usage involves the use of a mask, massage, or suppositories, while internal use involves the use of decoction, infusion, maceration, and other techniques (Eddouks et al., 2017). Decoction’s supremacy may thus be explained by the fact that it allows for the capture of the greatest amount of bioactive molecules and reduces or eliminates the toxic effects of some recipes (Noureddine et al., 2022).
FIGURE 3
3.4 Hepatic ailments categories and their informant consensus factor (ICF) values
In this study, we identified eight liver pathologies that were treated with medicinal plants in rural areas of North-East Morocco (Figure 4). The ICF values of the plant species cataloged in this investigation extended from a minimum of 0.25 to a maximum of 0.83. (Figure 5). This index has the highest value for liver congestion (ICF = 0.83), followed by hepatic colic (ICF = 0.80), liver cancer (ICF = 0.69), liver detoxification (ICF = 0.67), hepatitis (ICF = 0.66), jaundice (ICF = 0.54), liver stone (ICF = 0.50), and bile problems with ICF = 0.25. High values (around 1) of this index for liver congestion, hepatic colic, and liver cancer suggest that a small number of species were employed by many informants, reflecting a high level of consensus on the use of plants in the management of these illnesses. The low accord between both interviews was witnessed for biliary problems. This could be attributed to a lack of interaction and knowledge exchange among individuals (Al-Qura’n, 2005).
FIGURE 4
FIGURE 5
3.5 Fidelity level (FL)
According to the corresponding level of fidelity, we categorized the medicinal plants used to treat liver illness in Table 5. According to our findings, the level of fidelity of plant species for a particular liver condition ranged between 9.09% and 100%. Concerning hepatitis problems, the most important species according to the level of fidelity were Pimpinella anisum L. (FL = 100%), Laurus nobilis L. (FL = 100%), Lavandula dentata L. (FL = 75%), and Lupinus albus L. (FL = 66.67%). For the jaundice, Cocos nucifera L. (FL = 100%), Mentha pulegium L. (FL = 100%), Z. lotus (L.) Lam. (FL = 66.67%), and Agrimonia repens L. (FL = 66.67%) were the most important. The most widely known species in the hepatic colic group were Terminalia arjuna (Roxb. ex DC.) Wight & Arn. (FL = 100%), and Piper nigrum L. (FL = 60%). For liver detoxification, plants with the highest FL were Syzygium aromaticum (L.) Merr. & L.M. Perry (FL = 33.33%), Rumex vesicarius L. (FL = 33.33%), and Artemisia herba-alba Asso (FL = 28.57%). Nerium oleander L. (FL = 66.67%), and A. sativum L. (FL = 50%) were species with the highest fidelity level. For liver congestion, Citrus × aurantium L. (Fl = 66.67%) was the most important. In the end, Asparagus officinalis L. is the most important for liver stone and bile problems. The importance of these plants for the treatment of liver diseases in the study area could be due to their wide use in traditional Moroccan medicine to treat various diseases (Fakchich and Elachouri, 2021).
TABLE 5
| Category of illness | Name of species | Fidelity level (FL %) |
|---|---|---|
| Hepatitis | Pimpinella anisum L | 100.0 |
| Laurus nobilis L | 100.0 | |
| Lavandula dentata L | 75.00 | |
| Lupinus albus L | 66.67 | |
| Artemisia absinthium L | 50.00 | |
| Rosmarinus officinalis L | 50.00 | |
| Globularia alypum L | 40.00 | |
| Mentha pulegium L | 33.33 | |
| Curcuma longa L | 33.33 | |
| Cuminum cyminum L | 25.00 | |
| Salvia officinalis L | 25.00 | |
| Ocimum basilicum L | 25.00 | |
| Asparagus officinalis L | 16.67 | |
| Allium sativum L | 12.50 | |
| Jaundice | Cocos nucifera L | 100.0 |
| Mentha pulegium L | 100.0 | |
| Ziziphus lotus (L.) Lam | 66.67 | |
| Agrimonia repens L | 66.67 | |
| Ocimum basilicum L | 50.00 | |
| Cuminum cyminum L | 37.50 | |
| Armeria alliacea (Cav.) Hoffmanns. and Link | 33.33 | |
| Salvia officinalis L | 25.00 | |
| Zingiber officinale Roscoe | 25.00 | |
| Ceratonia siliqua L | 20 | |
| Asparagus officinalis L | 16.67 | |
| Artemisia absinthium L | 13.64 | |
| Hepatic colic | Terminalia arjuna (Roxb. ex DC.) Wight and Arn | 100.0 |
| Piper nigrum L | 60.00 | |
| Reichardia intermedia (Sch.Bip.) Samp | 50.00 | |
| Thymus vulgaris L | 50.00 | |
| Zingiber officinale Roscoe | 50.00 | |
| Cynara scolymus L | 37.50 | |
| Pistacia lentiscus L | 37.50 | |
| Apium nodiflorum (L.) Lag | 37.50 | |
| Artemisia absinthium L | 27.27 | |
| Detoxification | Syzygium aromaticum (L.) Merr. and L.M.Perry | 33.33 |
| Rumex vesicarius L | 33.33 | |
| Artemisia herba-alba Asso | 28.57 | |
| Cuminum cyminum L | 25.00 | |
| Rosmarinus officinalis L | 25.00 | |
| Artemisia absinthium L | 9.09 | |
| Liver cancer | Nerium oleander L | 66.67 |
| Allium sativum L | 50.00 | |
| Pistacia lentiscus L | 37.50 | |
| Nigella sativa L | 33.33 | |
| Salvia officinalis L | 25.00 | |
| Piper nigrum L | 20.00 | |
| Liver congestion | Citrus × aurantium L | 66.67 |
| Reichardia intermedia (Sch.Bip.) Samp | 50.00 | |
| Liver stones | Asparagus officinalis L | 16.67 |
| Bile problems | Asparagus officinalis L | 50.00 |
Fidelity level values of medicinal plants for each category of liver illness.
Bold indicates the best values.
3.6 Pharmacological confirmation data of the medicinal plants
The current ethnobotanical fieldwork confirmed that the inhabitants of northeastern Morocco has extensive ethnobotanical information concerning the use of herbal remedies in the treatment of liver conditions. These conventional data, which detailed a wide variety of quantitative factors, were particularly intriguing for the goal of bioprospecting to identify novel drugs to cure liver pathological conditions. It could be worthwhile to look up these plants’ pharmacological properties in the literature. According to the results of our bibliographic survey, of the 46 plant species registered for the treatment of liver diseases in the study area, 28 plant species from 20 botanical families have already been pharmacologically validated for liver diseases (Table 6). It can be concluded that the majority of them significantly reduce the risk of liver disorders. These findings demonstrated the potential of ethnobotanical knowledge as a preferable traditional database for plant species with beneficial therapeutic effects connected to liver illnesses. The pharmacological data collected for the plants selected during our survey were grouped in the Table 6.
TABLE 6
| Scientifique name | Used parts | Used extracts | Experimental model | Pharmacological uses | Therapeutic doses | Ref. |
|---|---|---|---|---|---|---|
| Allium sativum L | Leaves or bulbs | Aqueous extract | Rats | Hepatoprotective effect against acute ethanol-induced oxidative stress in rat liver | 250 mg/kg of b.w (for 5 days) | Nencini et al. (2010) |
| Garlic cloves | Ethanol extract | HepG2 cells | Cytoprotection against mycotoxins on HepG2 cells | 1% during 24 and 48 h | Juan-García et al. (2021a) | |
| Bulbs | Aqueous extract | Rats | Protective effect on alloxan-induced elevations of plasma biochemical factors of hepatic functions | 100 or 200 mg/kg of b.w/day (for 21 days) | Aprioku and Amah-Tariah (2017a) | |
| Artemisia absinthium L | Aerial parts | Aqueous extract | Mice | Protective effect against CCl4 and endotoxin-caused liver damage | 50–200 mg/kg of b.w (for 7 days) | Amat et al. (2010) |
| Aerial parts | Hydroalcoholic extract | Rats | Reduce serum levels of ALT, AST, and oxidative damage in rats to alleviate liver toxicity | 100 mg/kg of b.w (for 24 h) | Mohammadian et al. (2016) | |
| Aerial parts | Ethanol extract and its fractions, petroleum ether, and ethyl acetate | Human hepatoma BEL-7404 cells, and mouse hepatoma H22 cells | Induce apoptosis in Hepatocellular carcinoma cells via the endoplasmic reticulum stress and mitochondrial-dependent pathways to inhibit cell growth | 25–150 μg/mL (for 24, 48, and 72 h) | Wei et al. (2019) | |
| Leaves | Methanol and ethyl acetate extract | Rats | Hepatoprotective effect against diclofenac-induced liver toxicity in rats | 50–200 mg/kg of b.w/day (for 5 days) | Antonio et al. (2020) | |
| Asparagus officinalis L | Asparagus spears | Ethanolic and aqueous extracts | Mice | Prevent liver against high-fat diet | 200 mg/kg of b.w (for 10 weeks) | Zhu et al. (2010) |
| Roots | Hydroalcoholic extract | Rats | Prevent the liver from oxidative stress enhanced by cadmium chloride | 100–400 mg/kg of b.w (for 28 days) | Abedi et al. (2018) | |
| Ceratonia siliqua L | Leaves | Aqueous extract | Mouse hepatocellular carcinoma cell line (T1) | Anti-cancer effect against hepatocellular carcinoma cell line | 0.2–0.4 mg/mL (for 24 h) | Corsi et al. (2002) |
| Leaves | Hydroethanolic and ethyl acetate extracts | Rats | Protective effect against hepatotoxicity caused by CCl4 in rats | 250 mg/kg of b.w (for 8 days) | Hsouna et al. (2011) | |
| Pods | Aqueous extract | Mice | Improves liver fibrosis caused by Schistosoma mansoni | 300–600 mg/kg of b.w (daily for 10 days) | Al-Olayan et al. (2016) | |
| Pods | Aqueous extract | Rats | Hepatoprotective effect against dextran sulfate sodium in rats | 50–100 mg/kg of b.w (for 14 days) | Rtibi et al. (2016) | |
| Seeds | Powder | Rats | Protective effects on ethanol-iduiced hepatotoxicity in rats | 15% in diet supplementation | Temiz et al. (2015) | |
| Cocos nucifera L | Inflorescences | Acetone extract | Rats | Protective effect on acetaminophen-caused hepatotoxicity in rats | 100–400 mg/kg of b.w (for 14 days) | Chithra et al. (2020) |
| Unspecified | Essential oils | Rats | Improved hypothyroidism by the reduction of liver functions | 10% in diet (for 6 weeks) | Mohammed et al. (2020) | |
| Coriandrum sativum L | Fruits | Essential oils | Mice | Hepatoprotective effect against CCl4-induced liver damage | 0.13 g/kg of b.w (during 5 consecutive days) | Samojlik et al. (2010) |
| Fruits | Essential oils | Rats | Hepatoprotective effect against liver toxicity-induced by ibuprofen in rats | 40 mg/kg of b.w (for fourteen consecutive days) | Baghdadi et al. (2016) | |
| Leaves and seeds | Coriander sauces | Rabbits | Hepatoprotective effect against CCl4-induced toxicity in rabbits | 15 mL/kg of b.w | Iqbal et al. (2018) | |
| Areal parts and seeds | Aqueous extract | Rats | Hepatoprotective effect against hepatic injury provoked by lambda-cyhalothrin insecticide | 1% (w/w) in died (for 90 days) | Boutlelis et al. (2020) | |
| Crataegus monogyna Jacq | Fruits | Aqueous extract | Rats | Exhibits a protective effect on doxorubicin-induced the liver toxicity | 20 mg/kg of b.w (for 28 days) | Shalizar-jalali et al. (2013) |
| Crocus sativus L | Stigmas | Aqueous extract | Rats | Protective effects against chronic-stress induced oxidative damage liver in rats | 30 mg/kg of b.w (daily for 21 days) | Bandegi et al. (2014) |
| Flowers | Aqueous extract | Rats | Alleviate methotrexate-induced liver toxicity in rats | 80 mg/kg of b.w (for 10 days) | Hoshyar et al. (2019) | |
| Stigmas | Ethanolic extract | Rats | Protective effect on oxidative damages in aged male rat liver | 5–20 mg/kg of b.w (daily for 4-week) | Samarghandian et al. (2016) | |
| Petals and stigmas | Aqueous and ethanolic extracts | Rabbits | Hepatoprotective effect on amiodarone-provoked liver toxicity in rabbits | 100 mg/kg of b.w (for 3 days) | Riaz et al. (2016) | |
| Stigmas | Ethanolic extract | Rats | Beneficial effect for the liver | 0.35 g/kg of b.w (daily for 2 weeks) | Mohajeri et al. (2007) | |
| Petal | Hydroalcoholic extract | Rats | Anti-inflammatory effect in liver toxicity caused by alcohol consumption | 167.5–335 mg/kg of b.w (for 8 weeks) | Azizi et al. (2019) | |
| Petals | Hydroalcoholic extract | Rats | Hepatoprotective effect against acetaminophen provoked liver toxicity in male rats | 10–20 mg/kg of b.w (daily for 6 days) | Omidi et al. (2014) | |
| Tepals, stigmas and leaves | Hydroethanolic extract | Rats | Protective effects on CCl4-provoked acute liver toxicity in rats | 50 mg/kg of b.w (daily for 14 days) | Ouahhoud et al. (2021a) | |
| Curcuma longa L | Rhizomes | Ethanolic extract | Rats | Prevent on thioacetamide-provoked liver cirrhosis in rats | 250–500 mg/kg of b.w (for 8 weeks) | Salama et al. (2013) |
| Rhizomes | Ethanolic extract | Chicken | Hepatoprotective effect against aflatoxine-causing liver toxicity | 5 mg/kg of b.w (for 28 days) | Gholami-ahangaran et al. (2016) | |
| Rhizomes | n-Hexane extract | Rats | Protective effect on hepatotoxicity induced by ethanol | 200 mg/kg of b.w (for 28 days) | Nwozo et al. (2014) | |
| Rhizomes | Aqueous extract | Mice | Inhibiting hepatic oxidative stress and inflammatory cytokine secretion in ethanol-induced liver injury | 20 mg/kg of b.w (unspecified) | Uchio et al. (2017) | |
| Rhizomes | Hydro-alcoholic extract | Rats | Inhibiting hepatic oxidative stress in adriamycin-provoked liver toxicity | 100 mg/kg of b.w (for 4 weeks) | Article et al. (2024) | |
| Unspecified Unspecified | Rats | Protective effect on the liver toxicity provoked by AlCl3 | 40 mg/kg of b.w (for 8 weeks) | Khouja (2017) | ||
| Rhizomes | Ethyl acetate extract | Rats | Prevent the liver on alcohol-caused hepatotoxicity in rats | 100–350 mg/kg of b.w (for 14 days) | Antiya et al. (2021) | |
| Cynara scolymus L | Leaves | Aqueous extract | Rats | Inhibits cholesterol production in hepatocytes | 0.1–4.0 mg/mL | Gebhardt (1998) |
| Leaves | Ethanol extract | Rats | Prevent liver on CCL4-caused oxidative stress and liver damage | 1.5 g/kg of b.w (for 2 weeks) | Colak et al. (2016) | |
| Buds | Methanolic extracts | Rat Hepatocytes and on Human Hepatoma Cells | In vitro protection against oxidative stress in hepatocytes | 400–1,200 µM (for 24, 48, and 72 h) | Miccadei et al. (2008) | |
| Leaves | Ethanol extract | Rats | Hepatoprotective effect against obesity | 200–400 mg/kg of b.w (during 2 months daily) | Salem et al. (2019) | |
| Receptacle and bracts | Petroleum ether and ethyl acetate extracts | Rats | Reduced liver tissue lesions when damaged by thioacetamide | 1.5 g/kg of b.w (daily for 2 months) | El-Mesallamy et al. (2020) | |
| Roots | Hydro-alcoholic extract | Rats | Prevent liver on CCL4-provoked hepatotoxicity | 300–900 mg/kg of b.w (for 3 days) | Huseini et al. (2011) | |
| Leaves | Hydroethanolic extract | Rats | Inhibit hepatic oxidative stress in hepatotoxicity induced by diazinon | 1,500 mg/kg of b.w (for 15 days) | Ahmadi et al. (2019) | |
| Leaves | Aliphatic alcohols extract | HepG2 liver cells | Increased the mitochondrial dehydrogenase activities of the human liver HepG2 | 100 mg/mL for 48 h | Löhr et al. (2009) | |
| Leaves | Aqueous extract | HepG2 cells | Against genotoxicity of HepG2 cells, and modulate hydrogen peroxide DNA damage | 0.62–5.0 mg/mL (for 1 h) | Pereira et al. (2017) | |
| Leaves | Unspecified | Mice | Prevent the liver against obesity | 5% in fied (for 1 month) | Azeem et al. (2016) | |
| Glycyrrhiza glabra L | Roots | Aqueous extract | Rabbits | Protective effect on CCL4-caused acute liver toxicity | 2 g/kg of b.w (for 7 days) | Al-Razzuqi et al. (2012) |
| Roots | Aqueous and ethanol extracts | Rats | Protective effect on CCl4-caused acute liver toxicity | 250–500 mg/kg of b.w | Laylani (2016) | |
| Roots | Ethanolic extract | Rats | Prevent the liver against paracetamol provoked liver acute toxicity | 200 mg/kg of b.w (once a day for 7 days) | Tajua et al. (2011) | |
| Roots | Aqueous extract | Rabbits | Protective effect on CCl4 induced hepatotoxicity | 2 g/kg of b.w (daily for 7 days) | Omar and Omar (2014) | |
| Roots | Methanolic extract | HepG2 | Prevent the HepG2 cell line against H2O2 | 10–100 μg/mL | Shinde et al. (2016) | |
| Unspecified | Unspecified | Fish hepatocytes (Cyprinus carpio) | Hepatoprotective effect against CCl4-induced hepatocyte damage in common carp | 2.5–10 μg/mL (for 4 h) | Yin et al. (2011) | |
| Roots | Hydromethanolic extract | Mice | Hepatoprotective effect against CCl4 induced oxidative-stress mediated hepatotoxicity | 300 mg/kg of b.w (once a day up to 7days) | Sharma and Agrawal (2014) | |
| Hordeum vulgare L | Seeds | Unspecified | Rats | Lowering hyperlipidemia and improving liver enzymes and nearly restoring tissues of the liver to their normal structure | 10% in died (for 8 weeks) | Abulnaja and Rabey (2015) |
| Seeds | Methanolic extract | Rats | Prevent the liver on acetaminophen caused liver toxicity | 300–500 mg/kg of b.w (for 3 days) | Pa et al. (2010) | |
| Seeds | Methanolic extract | Rats | Hepatoprotective effect on ethanol-provoked hepatotoxicity | 300–500 mg/kg of b.w (for 18 days) | Shah et al. (2009) | |
| Laurus nobilis L | Leaves | Etahanol extarct | Rats | Protective effect on CCl4 provoked liver toxicity | 0.2 mL per 100 g rat mass | Gasparyan et al. (2015) |
| Leaves | Etahanol extarct | Rats | Hepatoprotective on sodium valproate-caused liver damage | 150 mg/kg of b.w (for 30 days) | Mahdi et al. (2022) | |
| Leaves | Methanol extarct | Rats | Prevent liver against paracetamol caused hepatotoxicity | 200–400 mg/kg of b.w (for 7 days) | Ravindran et al. (2013) | |
| Lavandula dentata L | Leaves | Aqueous extract | Mice | Hepatoprotective effect against thioacetamide provoked hepatic fibrosis in mice | 200 mg/kg of b.w (for 8 weeks) | Almalki (2022) |
| Malva parviflora L | Whole plant | Methanol extarct | Mice | Hepatoprotective effect against paracetamol- provoked hepatotoxicity in mice | 250 mg/kg of b.w (for 7 days) | Mallhi et al. (2014) |
| Mentha spicata L | Aerial parts | Aqueous extract | Rats | Protective effects against nicotine-induced toxicity in liver of rat | 100 mg/kg of b.w (for 2 months) | Ben Saad et al. (2018) |
| Nigella sativa L | Seeds | Essential oils | Mice | Protective effect on the liver injury provoked by Schistosoma mansoni | 2.5 and 5 mL/kg (for 2 weeks) | Mahmoud et al. (2002) |
| Seeds | Aqueous extract | Rats | Protective effect on CCl4-caused liver toxicity | 250–500 mg/kg of b.w (for 5 days) | Al-ghamdi (2015) | |
| Seeds | Essential oils | Rats | Hepatoprotective effects in CCl4-treated rats | 0.2 mL/kg (for 60 days) | Kanter et al. (2005) | |
| Seeds | Unspecified | Patients with non-alcoholic fatty liver disease | Improves biochemical and fatty liver changes in non-alcoholic fatty liver disease patients | 1g twice a day for 3 months | Hussain et al. (2017) | |
| Seeds | Aqueous extract | Mice | Protective effect against N-acetyl-p-aminophenol-induced injury in male mice | 0.25 g/kg of b.w (for 30 days) | Hamza and Al-harbi (2015) | |
| Unspecified | Essential oils | Rats | Protective effects on carboplatin-provoked hepatotoxicity | 4 mL/kg | Erisgin et al. (2019) | |
| Unspecified | Essential oils | Rats | Prevent the liver lesions induced by irradiation | 2 mg/kg for 4 weeks | Radwan and Mohamed (2018) | |
| Seeds | Hydroethanolic extract | Rats | Prevent liver injury on lipopolysaccharide-provoked hepatotoxicity | 100–400 mg/kg of b.w (for 2 weeks) | Rats et al. (2018) | |
| Seeds | Essential oils | Rats | Prevent liver against ethanol provoked oxidative stress and hepatotoxicity | 2.5–5.0 mL/kg of b.w (for 3 weeks) | Develi et al. (2014) | |
| Unspecified | Essential oils | Rats | Prevent against aluminium chloride-provoked liver damage | 2 mL/kg of b.w (once per day for 5 weeks) | Bouasla et al. (2014) | |
| Unspecified | Essential oils | Rats | Prevent the liver lesions induced by irradiation | 1 g/kg of b.w (for 10 days) | Cikman et al. (2014) | |
| Seeds | Aqueous extract | Rats | Protective and restorative impact on cholestatic liver failure in bile duct ligated rats, possibly via reduced neutrophil infiltration and oxidative stress in hepatocytes | 0.2 mL/kg of b.w (for 14 days) | Coban et al. (2010) | |
| Unspecified | Essential oils | Rats | Improves cisplatin’s effect on membrane enzymes, carbohydrate metabolism, and reactive oxygen species in liver | 2 mL/kg of b.w (for 14 days) | Farooqui et al. (2016a) | |
| Unspecified | Essential oils | Rats | Hepatoprotective Effect on CCl4 caused liver toxicity in adult rats | 2–4 mL/kg of b.w (for 2 weeks) | Danladi et al. (2013) | |
| Seeds | Unspecified | Mice | Protective effect against Dimethylaminoazobenzene provoked liver carcinogenesis in mice | 5% (for 32 weeks) | Mohamed et al. (2011) | |
| Unspecified | Essential oils | Rats | Protective effect in thioacetamide- provoked liver cirrhosis in albino rat | 5 mL/kg of b.w (for 8 weeks) | Nehar and Kumari (2013) | |
| Seeds | Hydroalcoholic extracts | Rats | Protective effect on CCl4-caused hepatotoxicity | 400–800 mg/kg of b.w (for 3 days) | Kingsley (2020) | |
| Unspecified | Essential oils | Rabbits | Protective effect on CCl4-caused hepatotoxicity | 0.2 mL/kg of b.w (for 7 days) | Al-razzuqi et al. (2011) | |
| Seeds | Aqueous extract | Rats | Protective effect on rifampicin caused hepatotoxicity | 2 g/kg of b.w (for 28 days) | Al-azzawi and Baraaj (2016) | |
| Seeds | Aqueous extract | Rats | Protective effect on thioacetamide-provoked liver fibrosis | 50 mg/kg of b.w (for 7 weeks) | Salem et al. (2017) | |
| Unspecified | Essential oils | Mice | Protective effect on diclofenac sodium and ibuprofen provoked hepatotoxicity | 2.5 mL/kg of b.w | Husna and Sajjad (2017) | |
| Seeds | Unspecified | Chicken | Hepatoprotective effect on aflatoxin-caused liver toxicity | 1% | Abosaleh et al. (2019) | |
| Unspecified | Essential oils | Rats | Reduced the hepatotoxicity provoked by ochratoxin A | 0.3 mL/kg of b.w (for 4 weeks) | Alhussaini (2015a) | |
| Unspecified | Essential oils | Rats | Protective effect on thioacetamide-provoked liver toxicity | 10 mL/kg of b.w (for 6 days) | Tanbek et al. (2017) | |
| Seeds | Unspecified | Rabbits | Protective effect in isoniazid-induced liver toxicity in rabbits | 500–1,000 mg/kg of b.w (for 20 days) | Panezai et al. (2022) | |
| Seeds | Hydro-alcoholic extract | Mice | Protective effect against diethyl phthalate induced changes in mitochondrial enzymatic activities in liver of mice | 150–300 mg/kg of b.w (for 30 days) | Prajapati and Verma (2022) | |
| Seeds | Unspecified | Mice | Protective effect against CCl4 provoked liver injury in mice | 4 mL/kg of b.w (for 3 weeks) | Aleem et al. (2020) | |
| Ocimum basilicum L | Leaves | Aqueous and ethanol extracts | Rats | Hepatoprotective effect on CCl4-induced liver fibrosis in rats | 200 mg/kg of b.w (for 6 weeks) | Yacout et al. (2012) |
| Leaves | Petroleum ether, chloroform, alcohol and Aqueous extracts | Goat liver | Hepatoprotective effect against H2O2 and CCl4 induced hepatoxicity in goat liver | 100 mg/kg of b.w (for 5 days) | Meera et al. (2009) | |
| Unspecified | Essential oils | Rats | Modulates hematotoxicity, reactive oxygen species ( ros, DNA damage, and cell cycle arrest caused by β-cyfluthrin in rat liver | 3 mL/kg of b.w (every day for a month) | Jebur et al. (2022) | |
| Leaves | Aqueous extract | Rats | Prevent liver on methotrexate-caused hepatotoxicity | 1% (for 42 days) | El Shahat et al. (2017) | |
| Leaves | Aqueous extract | Rats | Prevent hepatic damage caused by arsenic | 400 mg/kg of b.w (once a day for 5 weeks) | Osman et al. (2020) | |
| Leaves | Aqueous extract | Rats | Hepatoprotective effect on adriamycin-caused liver toxicity | 20 mg/kg of b.w (for 8 weeks) | Bayomy et al. (2016) | |
| Whole plant | Chloroform, diethylether, ethylacetate and methanol extracts | Rats | Hepatoprotective effect on acetaminophen-provoked liver injury | 1,200 mg/kg of b.w (for 7 days) | Asala et al. (2021) | |
| Olea europaea L | Leaves | Aqueous extract | Rats | Protective effect on CCl4-provoked liver toxicity | 80 mg/kg of b.w (for 10 days) | Ustuner et al. (2018) |
| Leaves | Unspecified | Rats | Protective effect in CCl4-caused hepatotoxicity | 80 mg/kg of b.w (for 3 days) | Vidičević et al. (2020) | |
| Fruit pulp | Ethanol, n-hexane, ethyl acetate (EA)extracts | Rats | Hepatoprotective effect against high-fat diet-fed | 100–300 mg/kg of b.w (for 28 days) | Kim et al. (2014) | |
| Piper nigrum L | Fruits | Methanol extract | Human liver microsomes | Prevent liver | 5% | Usia et al. (2005) |
| Seeds | hydroalcoholic extract | Mice | Hepatoprotective effects on concanavalin A-provoked liver toxicity | 400 mg/kg of b.w | Mushtaq et al. (2021) | |
| Fruits | Ethanol extract | Rats | Inhibited liver fibrosis induced by thioacetamide | 100 mg/kg of b.w (for 28 days) | Dinakar et al. (2010) | |
| Fruits | Essentiel oils | Mice | Hepatoprotective effect on CCl4-induced toxicity in mice | 2 g/kg of b.w (for 14 days) | Zhang et al. (2021) | |
| Pistacia lentiscus L | Unspecified | Essential oils | Rats | Hepatoprotective effect in rats intoxicated by CCl4 | 2–5 mL/kg of b.w (every 3 days for 15 days) | Maameri et al. (2015) |
| Rosmarinus officinalis L | Leaves | Methanol extract | Rats | Against CCl4-provoked liver cirrhosis | 200 mg/kg of b.w (for 12 weeks) | Alhussaini (2015b) |
| Leaves | Etahanol extarct | Mice | Limits weight gain and liver steatosis in mice fed a high-fat diet | 200 mg/kg of b.w (for 50 days) | Harach et al. (2010) | |
| Leaves | Etahanol extarct | Oncorhynchus mykiss | Reducing the rate of steatosis in the liver of rainbow trout | 0.4–3 g/kg of b.w (for 40 days) | Farooqui et al. (2016b) | |
| Leaves | Hydroalcoholic extract | Rats | Hepatoprotective effect of on acetaminophen-caused liver damage | 100–500 mg/kg of b.w (for 7 days) | Lucarini et al. (2014) | |
| Unspecified Unspecified | Rats | Prevent liver against etoposide chemotherapy-caused hepatotoxicity | 220 mg/kg of b.w (for 6 weeks) | Almakhatreh et al. (2019) | ||
| Leaves | Hydroalcoholic extract | Rats | Hepatoprotective effect on bile-duct ligation provoked toxicity | 500 mg/kg of b.w (for 14 days) | Sadeghi et al. (2020) | |
| Leaves | Ethanolic Extract | Rats | Prevent liver on alcohol-provoked hepatocytes damage | 200 mg/kg of b.w (for 90 days) | Aouad et al. (2021) | |
| Leaves | Aqueous extract | Rats | Protective effect on trichloroacetate-caused hepatotoxicity | 200 mg/kg of b.w (for 2 months) | Abozid and Farid (2018) | |
| Whole plant | Dichloromethan and methanol extract | HepG2 | Regulates metabolism in HepG2 Cells | 0 50 μg/mL (for 24 h) | Tu et al. (2013) | |
| Rumex vesicarius L | Whole plants | Methanolic extract | Rats | Hepatoprotective effect on CCl4-caused toxicity | 100–200 mg/kg of b.w (for 7 days) | Ganaie et al. (2015) |
| Whole plants | Methanolic extract | Rats | Protective effect in malathion hepatotoxicity | 200 mg/kg of b.w (for 28 days) | Mostafa et al. (2018) | |
| Salvia officinalis L | Unspecified | Essential oils | Mice | Hepatoprotective effect against high-fat diet exposition | 4 mg/kg of b.w (during 8 weeks) | Koubaa-Ghorbel et al. (2020a) |
| Unspecified | Essential oils | Rats | Hepatoprotective effects against vanadium-induced oxidative stress and histological changes in the rat liver | 15 mg/kg of b.w | Koubaa et al. (2021a) | |
| Flowers | Aqueous extract | Rats | Hepatoprotective effect against ethanol induced oxidative stress in rats | 50–200 mg/kg of b.w (for 15 days) | Jedidi et al. (2022a) | |
| Leaves | Hydromethanolic extract | Rats | Hepatoprotective effect against Aspergillus parasiticus Aflatoxin-caused liver damage in rats | 25–150 mg/kg of b.w | Parsai et al. (2015) | |
| Aerial parts | Hydroalcoholic extract | Rats | Hepatoprotective effect against isoniazid provoked hepatic damage in rats | 100–400 mg/kg of b.w (for 28 days) | Shahrzad et al. (2014a) | |
| Leaves | Ethanolic extract | HepG2 | Prevent HepG2 cells against oxidative stress | 0.01–100 mg/mL (for 24 h) | Kozics et al. (2013a) | |
| Syzygium aromaticum (L.) | Flower buds | Etahanol extarct | Rats | Protective effect on hepatotoxicity caused by thioacetamide | 800 mg/kg of b.w (for 3 days) | Prasad et al. (2010) |
| Terminalia arjuna (Roxb. ex DC.) Wight and Arn | Bark | Aqueous extract | Mice | Protect the liver tissues against CCl4-caused hepatotoxicity | 50 mg/kg of b.w (for 1 week) | Manna et al. (2006) |
| Bark | Ethanolic extract | HepG2 | Thherapeutic effects on human hepatoma cell line, HepG2, and exhibits its cytotoxicity to these cells, and the cell death is mediated by apoptosis | 20–100 mg/L (for 48 h) | Sivalokanathan et al. (2006) | |
| Bark | Aqueous extract | Rats | Hepatoprotective effect against isoniazid provoked toxicity in rats | 200 mg/kg of b.w (for 10 days) | Doorika and Ananthi (2002) | |
| Fruits | Aqueous and ethanol extracts | Mice | Protective effect on cadmium-caused hepatotoxicity | 100 mg/kg of b.w (for 7 days) | Ghosh et al. (2010a) | |
| Bark | Alcoholic and aqueous extracts | Human liver microsomes | Modulatory impacts on the enzyme activity of CYP3A4, CYP2D6, and CYP2C9 in hepatocyte microsomes | 2.5–75 μg/mL | Varghese et al. (2015) | |
| Bark | Aqueous extract | HepG2 | Attenuates toxicity provoked by tert-butyl hydroperoxide in HepG2 cell | 25–100 mg/mL | Shivananjappa et al. (2013) | |
| Bark | Aqueous extract | Rats | Prevent liver against acetaminophen | 250–500 mg/kg of b.w (for 14 days) | Kannappan et al. (2020) | |
| Bark | Aqueous extract | Rats | Protective effect against alcohol caused hepatoxicity in rats | 250–500 mg/kg of b.w | Ch et al. (2015) | |
| Bark | Aqueous extract | HepG2 | Reduce basal oxidative stress in HepG2 cells | 25–100 μg/mL | Shivananjappa and Joshi (2012) | |
| Leaves | Aqueous extract | Rats | Attenuated the physiological and histopathological alterations in liver provoked by cisplatin | 400 mg/kg of b.w (for 14 days) | Sneha et al. (2021) | |
| Bark | Aqueous extract | Rats | Protective effects against arsenic-caused aggravation of high fat diet-induced oxidative stress-mediated damages in liver | 20–60 mg/kg of b.w (for 8 days) | Dutta et al. (2014) | |
| Bark | Aqueous extract | Rats | Protective effect against adrenaline-induced hepatic damage in rats through an antioxidant mechanism | 10–40 mg/kg of b.w (for 5 days) | Ghosh et al. (2010b) | |
| Fruits | Ethanolic extaract | Mice | Hepatoprotective effect in acetaminophen intoxicated mice | 400 mg/kg of b.w | Saira et al. (2020) | |
| Bark | Aqueous extract | Rats | Protective effect on acetaminophen-provoked liver damage | 250–500 mg/kg of b.w (for 14 days) | Chester et al. (2017) | |
| Bark | Ethanolic extaract | Rats | Protective effect on paracetamol provoked liver toxicity | 200 mg/kg of b.w (once daily for 7 days) | Sangamithira et al. (2011) | |
| Stem bark | Alcohol extract | Rats | Hepatoprotective effect on CCl4-caused toxicity | 250–500 mg/kg of b.w (for 5 days) | Anbalagan et al. (2007) | |
| Thymus vulgaris L | Unspecified | Alcoholic extract | Broiler chickens | Regulates lipid metabolism in the liver | 0.2%–0.6% (for 42 days) | Abdulkarimi et al. (2011) |
| Unspecified | Essential oil | Rats | Enhances the total antioxidant potential of hepatocytes | 42.5 mg/kg of b.w | Youdim and Deans (1999) | |
| Leaves | Unspecified | Mice | Boost the activity of xenobiotic-metabolizing enzymes in the liver | 0.5%–2.0% (for 7 days) | Sasaki et al. (2005) | |
| Unspecified | Essential oils | Japanese quails (Coturnix coturnix japonica) | Ameliore in vivo antioxidant activity in the liver | 150–450 mg/kg of b.w | Nutrition et al. (2017) | |
| Leaves, flowers and stems | Aqueous extract | Rats | Hepatoprotective effect against toxicity in rats exposed to aluminum | 150 mg/kg of b.w (daily for 90 days) | Mokrane et al. (2020) | |
| Unspecified | Aqueous extract | Rats | Improved liver injury induced by paclitaxel in rats | 4.5–18 mg/kg of b.w (for 2 weeks) | Salahshoor et al. (2019) | |
| Aerial parts | Aqueous extract | Rats | Prevent liver against dexamethasone-provoked liver damage | 500 mg/kg of b.w (for 8 weeks) | Abou-Seif et al. (2019) | |
| Leaves | Ethanolic extaract | HepG2 | Protective the HepG2 cells oxidative stress | 100 mg/mL | Kozics et al. (2013b) | |
| Ziziphus lotus (L.) Lam | Fruits | Aqueous extract | Rats | Protective effect on CCl4 provoked liver toxicity | 200 and 400 mg/kg for 14 days | Bencheikh et al. (2019) |
Pharmacological outcomes of medicinal plants cited by locals to cure liver ailments.
According to the results of our ethnobotanical survey, C. cyminum L. (UV = 0.1065), A. sativum L. (UV = 0.1015), S. officinalis L. (UV = 0.0761), Asparagus officinalis L. (UV = 0.0558), and Z. lotus (L.) Lam. (UV = 0.0457) are the medical species commonly used in Northeastern Morocco for the treatment or prevention of liver problems. To support the use of these plants in conventional medicine, it may be interesting to further explore and discuss their pharmacological properties related to liver problems. To this goal, we shall explore the pharmacological potential of these herbs in the following paragraphs to validate their benefits against liver diseases:
Allium sativum L. is ranked as the second most used species (UV = 0.1015) for the treatment of liver diseases. According to ethnobotanical findings, this plant is widely used in rural areas of northeastern Morocco for its hepatoprotective effect, against liver cancer, and viral infections (hepatitis). The leaves and bulb of A. sativum have demonstrated antioxidant and hepatoprotective effects against ethanol-induced hepatotoxicity in rats (Nencini et al., 2010). Indeed, the administration of an extract of the leaves or bulbs of A. sativum At a dose of 250 mg/kg, the Glutathion reductase (GR), catalase (CAT), and superoxide dismutase (SOD) activities were restored, and the levels of malondialdehyde, ascorbic acid, and glutathion were reduced and oxidized in the liver tissue of rats exposed to ethanol (Nencini et al., 2010). A study also discovered that A. sativum has a cytoprotective impact in HepG2 cells submitted to mycotoxines, specifically Beauvericin, α-Zearalenol and β-Zearalenol (Juan-García et al., 2021b). The presence of antioxidant compounds, according to the authors, is responsible for this cytoprotective effect, which involves the activation of defensive pathways as an enzymatic defence mechanism from within cells, the control of the cell cycle, and cell death, all of which can be provoked by these mycotoxines (Juan-García et al., 2021b). Another research revealed that an aqueous extract of garlic bulbs reduces alloxane elevation of biological parameters of liver and kidney functions in rats (Aprioku and Amah-Tariah, 2017b). According to prior study, garlic includes a number of bioactive components such as organosulfur compounds, saponins, and phenolic compounds (Bradley et al., 2016; Diretto et al., 2017). Organosulfur compounds such as diallyl thiosulfonate (allicin), diallyl sulfide, diallyl disulfide, diallyl trisulfide, E/Z-ajoene, S-allyl-cysteine, and S-allyl-cysteine sulfoxide have been claimed to be the principal active phytochemicals found in garlic (Figure 5) (Yoo D. Y. et al., 2014; Yoo et al., 2014 M.; Kodera et al., 2017; Mansingh et al., 2018). These compounds were discovered to be related to the plant’s powerful antioxidant and antitumor ability (Bagul et al., 2015).
Asparagus officinalis L. this plant is ranked third among the plants most commonly used for the treatment of liver diseases by the Moroccan population. It is frequently used to treat biliary problems, hepatic stones, hepatitis, and jaundice, as shown in Table 3. It has been reported that the aqueous and ethanolic extract of A. officinalis have hypolipidemic and hepatoprotective effects in mice fed a high-fat diet (Zhu et al., 2010). According to the findings of this study, daily treatment of 200 mg/kg of either ethanolic or aqueous extract for 8 weeks enhanced lipid parameters, transaminase (Alanine and Aspartate) activity, superoxide dismutase (SOD) and antioxidant capacity, and hepatic malondialdehyde levels. In addition, an in vivo research indicate that the aqueous extract of A. officinalis roots has protective properties on cadmium chloride-induced liver injury in rats (Abedi et al., 2018). This investigation found that treatment by aqueous extract of A. officinalis roots at 200 and 400 mg/kg for 28 days significantly restored liver biomarkers in cadmium chloride poisoned rats. Several phytochemical investigations have revealed that the main bioactive compounds found in asparagus include phenolic compounds, sterols, and saponins (Jang et al., 2004; Fuentes-Alventosa et al., 2013). Asparanin A, Asparoffin C, Asparoffin D, Asparenyol, Gobicusin B, Protodioscin and 1-methoxy-2-hydroxy-4-[5-(4-hydroxyphenoxy)-3-penten1-ynyl] phenol are the main phytochemicals found in asparagus, with Rutin (Quercetin 3-rutinoside) as the major compound (Figure 5) (Fan et al., 2015). These compounds’ antioxidant action is well-known (Sun et al., 2007; Solana et al., 2015; Slatnar et al., 2018), that may contribute in the hepatoprotective effects of the plant.
Salvia officinalis L. This plant is widely used in folk medicine in North East Morocco to treat liver failure. It is ranked fourth of the most commonly used plants, with a use value of 0.0761. According to our findings, various parts of this plant have traditionally been used to treat jaundice, hepatitis, and liver cancer in the study site. Several preclinical investigations on plant parts were carried out to examine its medicinal qualities for liver failure. In fact, 8 weeks of daily administration of S. officinalis essential oil at 4 mg/kg enhanced hyperlipidemia, hepatic, and renal lesions in mice fed a high-fat diet (Koubaa-Ghorbel et al., 2020b). This effect of S. officinalis essential oil was more effective than that of simvastatin (standard drug for this purpose). In addition, daily intake of 15 mg/kg of the essential oil of S. officinalis showed a protective effect against vanadium-induced hepatotoxicity in Wistar rats (Koubaa et al., 2021b). The treatment of rats with 200 mg/kg of S. officinalis aqueous extract for 15 days showed protective effects against ethanol-induced hepatotoxicity (Jedidi et al., 2022b). According to the same authors, this effect is reflected in the improvement of plasma transaminase activity and the restoration of hepatocyte structure in rats poisoned with ethanol. Besides, it was shown that administering a hydroalcoholic extract of S. officinalis at a dose of 250 mg/kg protected rats from isoniazid-induced hepatotoxicity (Shahrzad et al., 2014b). Furthermore, a previous investigation showed that an ethanolic extract of S. officinalis leaves protects human HepG2 cells from hydrogen peroxide and 2,3-dimethoxy-1,4-naphthoquinone-induced DNA damage (Kozics et al., 2013b). As shown in Figure 6, common sage contains a variety of biologically active compounds, primarily two types of relatively abundant phenolic components: phenolic acids (caffeic, vanillic, ferulic, and rosmarinic acids) and flavonoids (luteolin, apigenin, and quercetin) (Lu and Foo, 2002; Roby et al., 2013). These phenolic components are well-known as hepatoprotective agents (Kiokias and Oreopoulou, 2021; Venmathi Maran et al., 2022).
FIGURE 6
Ziziphus lotus (L.) Lam. According to our ethnobotanical study conducted in several parts of the Moroccan North-East, this plant ranks sixth among the most commonly utilized herbs to cure liver disorders. Indeed, the leaves and fruits of this plant were utilized to treat jaundice, hepatic colic, and hepatitis in the research region. Previous pharmacological work has demonstrated that Z. lotus extracts exert hepatoprotective effects at the preclinical stage. In a rat investigation, an aqueous extract of Z. lotus fruits was found to have hepatoprotective properties against CCl4-induced liver damage (Bencheikh et al., 2019). The findings of this study indicate that administration of aqueous extract of Z. lotus fruits at doses of 200 and 400 mg/kg restored the biochemical parameters (liver biomarkers) altered during hepatotoxicity induced by CCl4 injections in rats. Similarly, it has been reported that treatment of rats with the aqueous extract of Z. lotus fruit at doses of 200 and 400 mg/kg protects the liver and kidney from gentamicin poisoning (Bencheikh et al., 2021b). In the literature, it has been well demonstrated that the hepatotoxicity caused by the agent CCl4 and gentamicin is related to the oxidative stress caused by these chemical compounds (Lin and Huang, 2000; Achuthan et al., 2003). In this context, several authors confirm that the use of natural antioxidants to fight against the oxidative stress caused by CCl4 and gentamicin is the best strategy to prevent hepatotoxicity produced by these hepatotoxic substances (Bencheikh et al., 2021a; Bouhrim et al., 2021; Ouahhoud et al., 2021b). Extracts of Z. lotus fruits are high in phenolic compounds such as Rutin, Naringin, Chlorogenic acid, Rosmarinic acid, Quercetin, Cat-echin, Epicatechin, Sinapic acid, Resveratrol, and Caffeic acid, according to phytochemical research (Figure 6) (Marmouzi et al., 2019; Bencheikh et al., 2021c; 2021d). These photochemical compounds thanks to their antioxidant powers could be responsible for the hypatoprotective effects.
4 Conclusion
This ethnobotanical study reveals that locals in remote areas of northern Morocco possess extensive traditional knowledge about using medicinal plants to treat liver diseases, reflecting the region’s floristic richness. The findings demonstrate the potential of these herbs in addressing liver-related health issues within these communities. However, caution is necessary when using these remedies. The study is limited by its small sample size and lack of a control group, which may affect the robustness of the conclusions.
Further research is essential to evaluate the pharmacological benefits and phytochemical components of these plants, identify active ingredients, and confirm their clinical efficacy. Additionally, safety data are needed to standardize dosages and ensure safe use. Addressing these limitations will help in the development of effective medications derived from these medicinal plants for liver disease treatment.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.
Author contributions
NB: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing–original draft, Writing–review and editing. AE: Formal Analysis, Investigation, Software, Validation, Writing–original draft, Writing–review and editing. AB: Formal Analysis, Investigation, Software, Writing–original draft, Writing–review and editing. MB: Data curation, Investigation, Methodology, Software, Writing–review and editing. AA: Formal Analysis, Validation, Writing–review and editing. MA: Formal Analysis, Resources, Validation, Visualization, Writing–review and editing. RM: Funding acquisition, Resources, Validation, Writing–review and editing. HA-Y: Funding acquisition, Resources, Writing–review and editing. BE: Investigation, Validation, Writing–review and editing. ME: Formal Analysis, Resources, Validation, Visualization, Writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Researchers Supporting Project number (RSP 2024R119), King Saud University, Riyadh, Saudi Arabia.
Acknowledgments
The authors extend their appreciation to Researchers Supporting Project number (RSP 2024R119), King Saud University, Riyadh, Saudi Arabia for funding this work.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbdulkarimiR.DaneshyarM.AghazadehA. (2011). Thyme (Thymus vulgaris) extract consumption darkens liver, lowers blood cholesterol, proportional liver and abdominal fat weights in broiler chickens. Ital. J. Anim. Sci.10, e20. 10.4081/ijas.2011.e20
2
AbediH. A.JahromiH. K.SadeghiN.AmjadiS. P.JahromiZ. K. (2018). Evaluating the effect of aqueous extract of the roots of valuating the effect of aqueous extract of the roots of native edible asparagus in Iran (asparagus officinalis L.) on the ative edible asparagus in Iran (Asparagus officinalis L) on the concentratio. J. Fundam. Appl. Sci.4, 9–10. 10.4314/jfas.v8i2s.161
3
AbosalehS.SalamaM. F.HassanM. Z. (2019). The possible ameliorative effect of nigella sativa on aflatoxin-induced liver damage in chicken. Alex J. Vet. Sci.63, 113–120. 10.5455/ajvs.73879
4
Abou-SeifH. S.HozayenW. G.HashemK. S. (2019). Thymus vulgaris extract modulates dexamethasone induced liver injury and restores the hepatic antioxidant redox system. Beni Suef Univ. J. Basic Appl. Sci.8, 21–29. 10.1186/s43088-019-0021-0
5
AbozidM. M.FaridH. E. A. (2018). Protective role and antioxidant activity of aqueous extract of rosmarinus officinalis against trichloroacetate-induced toxicity in liver of male rats. Asian J. Pharm. Clin. Res.11, 420–424. 10.22159/ajpcr.2018.v11i6.25353
6
AbulnajaK. O.RabeyH. A.El (2015). The efficiency of barley (hordeum vulgare) bran in ameliorating blood and treating fatty heart and liver of male rats. Evidence-Based Complementary Altern. Med.16, 13. 10.1155/2015/740716
7
AchuthanC. R.BabuB. H.PadikkalaJ. (2003). Antioxidant and hepatoprotective effects of Rosa damascena. Pharm. Biol.41, 357–361. 10.1076/phbi.41.5.357.15945
8
AdeliM.SamavatiV. (2014). Studies on the steady shear flow behavior and chemical properties of water-soluble polysaccharide from Ziziphus lotus fruit. Int. J. Biol. Macromol.72, 580–587. 10.1016/j.ijbiomac.2014.08.047
9
AhmadiA.HeidarianE.Ghatreh-SamaniK. (2019). Modulatory effects of artichoke (Cynara scolymus L.) leaf extract against oxidative stress and hepatic TNF- α gene expression in acute diazinon-induced liver injury in rats. J. Basic Clin. Physiol. Pharmacol.2019, 1–10. 10.1515/jbcpp-2018-0180
10
Alami MerrouniI.ElachouriM. (2021). Anticancer medicinal plants used by Moroccan people: ethnobotanical, preclinical, phytochemical and clinical evidence. J. Ethnopharmacol.266, 113435. 10.1016/j.jep.2020.113435
11
Alami MerrouniI.KharchoufaL.BencheikhN.ElachouriM. (2021). Ethnobotanical profile of medicinal plants used by people of North-eastern Morocco: cross-cultural and historical approach (part I). Ethnobot. Res. Appl.21, 1–45. 10.32859/ERA.21.34.1-45
12
Al-azzawiA. F. S.BaraajA. H. (2016). Histological and biochemical study of nigella sativa seeds effects on liver of male albino rats treated with rifampicin. Iraqi J. Sci.57, 2829–2839.
13
AleemB.HingoroM. A.AwanH.AleemF.MastoiA. G.MastorS. M. (2020). Effects of nigella sativa extract against carbon tetrachloride induced liver injury in Swiss albino male mice. JKCD45, 1–6.
14
Al-ghamdiM. (2015). Protective effect of Nigella sativa seeds against carbon tetrachloride-induced liver damage. Am. J. Chin. Med. Gard. City N Y31, 721–728. 10.1142/S0192415X03001399
15
AlhussainiM. S. (2015a). Protective role of nigella sativa oil on ochratoxin A toxicity in liver and kidney of male albino rats: histological and histochemical studies. J. klagenfrt Austria21, 59–77.
16
AlhussainiM. S. (2015b). Protective role of nigella sativa oil on ochratoxin A toxicity in liver and kidney of male albino rats: histological and histochemical studies. J. klagenfrt Austria21, 59–77.
17
AlmakhatrehM.HafezE.ToussonE.MasoudA. (2019). Biochemical and molecular studies on the role of rosemary (rosmarinus officinalis) extract in reducing liver and kidney toxicity due to etoposide in male rats. Asian J. Res. Med. Pharm. Sci.7, 1–11. 10.9734/ajrimps/2019/v7i430126
18
AlmalkiD. A. (2022). Hepatoprotective Effect of Lavandula dentata leaves extracts on Thioacetamide- Induced hepatic fibrosis in male albino mice. Curr. Sci. Int.11, 217–223. 10.36632/csi/2022.11.2.16
19
Al-OlayanE. M.El-KhadragyM. F.AlajmiR. A.OthmanM. S.BauomyA. A.IbrahimS. R.et al (2016). Ceratonia siliqua pod extract ameliorates Schistosoma mansoni-induced liver fibrosis and oxidative stress. BMC Complement. Altern. Med.16, 434–511. 10.1186/s12906-016-1389-1
20
Al-Qura’nS. (2005). Ethnobotanical survey of folk toxic plants in southern part of Jordan. Toxicon46, 119–129. 10.1016/j.toxicon.2005.04.010
21
Al-RazzuqiR. A.Al-JawadF. H.Al- HussainiA., (2012). Hepatoprotective effect of Glycyrrhiza glabra in carbon tetrachloride-induced model of acute liver injury. J. Phys. Pharm. Adv.7, 259–263.
22
Al-razzuqiR. A. M.Al-hussainiJ. A.Al-jebooriA. A. (2011). Protective effect of Nigella sativa against carbon tetrachlorideinduced acute liver injury in experimental rabbit models. Int. J. Green Pharm.41, 198–200. 10.4103/0973-8258.91227
23
Al-snafiA. E. (2017). The pharmacological activities of Cuminum cyminum - a review. IOSR J. Pharm.6, 46–65.
24
AmatN.UpurH.BlažekovićB. (2010). In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice. J. Ethnopharmacol.131, 478–484. 10.1016/j.jep.2010.07.023
25
AnbalaganN.MallikaM.KuruvillaS.PrasadM. V. V.PatraA.BalakrishnaK. (2007). Antioxidant and hepatoprotective activities of alcoholic extract of Terminalia arjuna. Nat. Product. Sci.13, 105–109.
26
AndalluB.RamyaV. (2007). Anti-hyperglycemic, cholesterol-lowering and HDL–raising effects of cumin (Cuminum cyminum) seeds in type 2 diabetes. J. Nat. Remedies7, 142–149. 10.18311/jnr/2007/207
27
AntiyaM. C.EtengO. E.AlimiM. A.AdeyiO.AdeyiE. O.OkoloI.et al (2021). Hepatoprotective effect of ethyl acetate extract of Curcuma longa on alcohol-induced liver damage in female Wistar rats. Biokemistri33, 97–104.
28
AntonioS. G. W.Silva-Correa CarmenR.Villarreal-La Torre VíctorE.Cruzado-Razco JoséL.Calderón-Peña AbhelA.Aspajo-Villalaz CinthyaL.et al (2020). Hepatoprotective and nephroprotective activity of artemisia absinthium l. On diclofenac-induced toxicity in rats. Pharmacogn. J.12, 1032–1041. 10.5530/PJ.2020.12.146
29
AouadR. F.BoufadiM. Y.AdliD. E. H.Moulai-HaceneF.KahloulaK.SlimaniM. (2021). Chemical composition and protective effect of rosmarinus officinalis on alcohol-induced serum hepatic changes and liver injury in male rats. Pharmacogn. J.13, 1205–1215. 10.5530/pj.2021.13.154
30
A.P.G III (2009). An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III. Botanical J. Linn. Soc.161, 105–121. 10.1111/j.1095-8339.2009.00996.x
31
ApriokuJ.Amah-TariahF. (2017a). Garlic (Allium sativum L.) protects hepatic and renal toxicity of alloxan in rats. J. Pharm. Res. Int.17, 1–7. 10.9734/jpri/2017/34909
32
ApriokuJ.Amah-TariahF. (2017b). Garlic (Allium sativum L.) protects hepatic and renal toxicity of alloxan in rats. J. Pharm. Res. Int.17, 1–7. 10.9734/jpri/2017/34909
33
ArticleO.KhazdairM. R.MohebbatiR.KarimiS.AbbasnezhadA. (2024). The protective effects of Curcuma longa extract on oxidative stress markers in the liver induced by Adriamycin in rats. Physiology Pharmacol.20, 31–37.
34
AsalaT. M.AbatanM. O.SalamiS. A.OluwatosinO.AkanbiO. B.RowaiyeA. B.et al (2021). The ameliorative effect of the solvent extracts of Ocimum basilicum against acetaminophen-induced liver damage in albino rats. J. Phytomedicine Ther.20, 615–623. 10.4314/jopat.v20i1.4
35
AsraniS. K.DevarbhaviH.EatonJ.KamathP. S. (2019). Burden of liver diseases in the world. J. Hepatol.70, 151–171. 10.1016/j.jhep.2018.09.014
36
AzeemE. M. A.ElAlaaB.ZakariaZ. (2016). Anti-obesity and anti-fatty liver effects of cynara scolymus L. Leaf extract in mice under diet-induced obesity. Int. J. Biochem. Res. Rev.11, 1–11. 10.9734/IJBCRR/2016/23807
37
AziziM.AbbasiN.MohamadpourM.BakhtiyariS.AsadiS.ShirzadpourE.et al (2019). Investigating the effect of Crocus sativus L. Petal hydroalcoholic extract on inflammatory and enzymatic indices resulting from alcohol use in kidney and liver of male rats. J. Inflamm. Res.12, 269–283. 10.2147/JIR.S216125
38
BaghdadiH. H.El-DemerdashF. M.HusseinS.RadwanE. H. (2016). The protective effect of Coriandrum sativum L. oil against liver toxicity induced by Ibuprofen in rats. J. Biosci. Appl. Res.2, 197–202. 10.21608/jbaar.2016.106944
39
BagulM.KakumanuS.WilsonT. A. (2015). Crude garlic extract inhibits cell proliferation and induces cell cycle arrest and apoptosis of cancer cells in vitro. J. Med. Food18, 731–737. 10.1089/jmf.2014.0064
40
BandegiA. R.Rashidy-pourA.VafaeiA. A.GhadrdoostB. (2014). Protective effects of crocus sativus L. Extract and crocin against chronic-stress induced oxidative damage of brain, liver and kidneys in rats. Adv. Pharm. Bull.4, 493–499. 10.5681/apb.2014.073
41
BayomyM. F. F.SakrS. A.MG. S. E. (2016). Biochemical and histological studies on the possible protective impact of the herb basil (Ocimum basilicum) on adriamycin induced toxicity in rats. I. Influence on the liver. J. Biosci. Appl. Res.2, 634–640. 10.21608/jbaar.2016.109005
42
BellakhdarJ.ClaisseR.FleurentinJ.YounosC. (1991). Repertory of standard herbal drugs in the Moroccan pharmacopoeia. J. Ethnopharmacol.35, 123–143. 10.1016/0378-8741(91)90064-k
43
Ben AkkaF.SalhiS.BenkhnigueO.DahmaniJ.DouiraA.ZidaneL. (2019). Ethnobotanical study of medicinal plants used in the region of Middle Oum Rbia (Morocco). Plant Arch.19, 2005–2017.
44
BenarbaB. (2016). Medicinal plants used by traditional healers from South-West Algeria: an ethnobotanical study. J. Intercult. Ethnopharmacol.5, 320–330. 10.5455/jice.20160814115725
45
BencheikhN.BouhrimM.KharchoufaL.Al KamalyO. M.MechchateH.Es-safiI.et al (2021a). The nephroprotective effect of zizyphus lotus L. (desf.) fruits in a gentamicin-induced acute kidney injury model in rats: a biochemical and histopathological investigation. Molecules26, 4806. 10.3390/molecules26164806
46
BencheikhN.BouhrimM.KharchoufaL.ChoukriM.BnouhamM.ElachouriM. (2019). Protective effect of Zizyphus lotus L.(Desf.) fruit against CCl4-induced acute liver injury in rat. Evidence-based Complementary Altern. Med.2019, 6161593. 10.1155/2019/6161593
47
BencheikhN.BouhrimM.KharchoufaL.KamalyO.AlM.MechchateH.et al (2021b). The nephroprotective effect of Zizyphus lotus L. (desf.) fruits in a gentamicin-induced acute kidney injury model in rats: a biochemical and histopathological investigation. Molecules26, 4806. 10.3390/molecules26164806
48
BencheikhN.BouhrimM.KharchoufaL.KamalyO.AlM.MechchateH.et al (2021c). The nephroprotective effect of Zizyphus lotus L. (desf.) fruits in a gentamicin-induced acute kidney injury model in rats: a biochemical and histopathological investigation. Molecules26, 4806. 10.3390/molecules26164806
49
BencheikhN.BouhrimM.MerrouniI. A.BoutahiriS.LegssyerA.ElachouriM.et al (2021d). Antihyperlipidemic and antioxidant activities of flavonoid-rich extract of Ziziphus lotus (L.) Lam. Fruits. Appl. Sci.11, 7788. 10.3390/app11177788
50
BencheikhN.ElachouriM.SubhashC. M. (2022). Ethnobotanical, pharmacological, phytochemical, and clinical investigations on Moroccan medicinal plants traditionally used for the management of renal dysfunctions. J. Ethnopharmacol.292, 115178. 10.1016/j.jep.2022.115178
51
BencheikhN.ElbouzidiA.KharchoufaL.OuassouH.MerrouniI. A.MechchateH.et al (2021e). Inventory of medicinal plants used traditionally to manage kidney diseases in north-eastern Morocco: ethnobotanical fieldwork and pharmacological evidence. Plants10, 1966. 10.3390/plants10091966
52
BencheikhN.RadiF. Z.FakchichJ.ElbouzidiA.OuahhoudS. (2023). Pharmacological properties of Ziziphus lotus (L.) Lam.: a comprehensive review. Pharmaceuticals16, 36. 10.3390/ph16040575
53
BendaifH.HarirM.YahiaouiM.SouilahN.HechaichiF.Zohra Djamel MiaraM.et al (2021). Ethnobotanical survey of herbal remedies traditionally used in El Hammadia (Southern region of the province of Bordj Bou Arreridj, Algeria). Algerian J. Biosci.02, 6–15.
54
BenítezG.González-TejeroM. R.Molero-MesaJ. (2010). Pharmaceutical ethnobotany in the western part of Granada province (southern Spain): ethnopharmacological synthesis. J. Ethnopharmacol.129, 87–105. 10.1016/j.jep.2010.02.016
55
Ben SaadA.RjeibiI.AlimiH.NcibS.BouhamdaT.ZouariN. (2018). Protective effects of Mentha Spicata against nicotine-induced toxicity in liver and erythrocytes of Wistar rats. Appl. Physiology, Nutr. Metabolism43, 77–83. 10.1139/apnm-2017-0144
56
BhagawanW. S.EkasariW.AgilM. (2023a). Ethnopharmacology of medicinal plants used by the tenggerese community in bromo tengger semeru national Park, Indonesia. Biodiversitas24. 10.13057/biodiv/d241028
57
BhagawanW. S.EkasariW.AgilM. (2023b). Ethnopharmacology of medicinal plants used by the tenggerese community in bromo tengger semeru national Park, Indonesia. Biodiversitas J. Biol. Divers.24. 10.13057/biodiv/d241028
58
BhagawanW. S.EkasariW.AgilM. (2024). Ethnobotanical survey of herbal steam baths among the tenggerese community in bromo tengger semeru national Park, Indonesia, IOP Conf. Ser. Earth Environ. Sci.1352, 12103.10.1088/1755-1315/1352/1/012103
59
BhagawanW. S.SuproboriniA.PutriD. L. P.NurfatmaA.PutraR. T. (2022). Ethnomedicinal study, phytochemical characterization, and pharmacological confirmation of selected medicinal plant on the northern slope of Mount Wilis, East Java, Indonesia. Biodiversitas J. Biol. Divers.23. 10.13057/biodiv/d230855
60
BouaslaI.BouaslaA.BoumendjelA.MessarahM.AbdennourC.BoulakoudM. S.et al (2014). Nigella sativa oil reduces aluminium chloride-induced oxidative injury in liver and erythrocytes of rats. Biol. Trace Elem. Res.43, 252–261. 10.1007/s12011-014-0114-5
61
BouhrimM.BencheikhN.ImtaraH.DaoudiN. E.MechchateH.OuassouH.et al (2021). Protective effect of opuntia dillenii (ker gawl.) haw. Seed oil on gentamicin-induced nephrotoxicity: a biochemical and histological analysis. Sci. World J.7, 2173012. 10.1155/2021/2173012
62
BoutlelisD. A.MouniaB.SalahB.BordjibaO. (2020). Antioxidant and hepatoprotective Potential of Coriandrum sativum L. against hepatic injury by Lambda-cyhalothrin insecticide. J. Drug Deliv. Ther.10, 182–188. 10.22270/jddt.v10i3-s.4186
63
BradleyJ. M.OrganC. L.LeferD. J. (2016). Garlic-derived organic polysulfides and myocardial protection. J. Nutr.146, 403S-409S–409S. 10.3945/jn.114.208066
64
ChN.VardhanA.ReddyD. (2015). Protective effect of aqueous bark extract of Terminalia arjunaa against alcohol-induced hepato and nephrotoxicity in rats. Intern Natl. J. Phytomedicine7, 142–153.
65
ChesterK.ZahiruddinS.AhmadA.KhanW.PaliwalS.AhmadS. (2017). Antioxidant effect of Terminalia arjuna extract against acetaminophen-induced hepatotoxicity via the regulation of cytochrome P450 2E1, phosphatidylinositol-3-kinase/protein kinase B. Pharmacogn. Mag.13 (Suppl. l), 179–188. 10.4103/pm.pm
66
ChithraM. A.IjinuT. P.KharkwalH.SharmaR. K.JanardhananK. K.PushpangadanP.et al (2020). Cocos nucifera l. Inflorescence extract: an effective hepatoprotective agent. Indian J. Traditional Knowl.19, 128–136.
67
CikmanO.OzkanA.AlkisH.TaysiS. (2014). Radioprotective effects of nigella sativa oil against oxidative stress in liver tissue of rats exposed to total head irradiation. J. of Investigative Surg.27, 262–266. 10.3109/08941939.2014.898811
68
CobanS.YildizF.TerziA.AlB.AksoyN.BitirenM.et al (2010). The effects of Nigella sativa on bile duct ligation induced-liver injury in rats. Cell. Biochem. Funct.28, 83–88. 10.1002/cbf.1624
69
ColakE.UstunerM. C.TekinN.ColakE.BurukogluD.DegirmenciI.et al (2016). The hepatocurative effects of Cynara scolymus L. leaf extract on carbon tetrachloride-induced oxidative stress and hepatic injury in rats. Springerplus5, 216–219. 10.1186/s40064-016-1894-1
70
CorsiL.AvalloneR.CosenzaF.FarinaF.BaraldiC.BaraldiM. (2002). Antiproliferative effects of Ceratonia siliqua L. on mouse hepatocellular carcinoma cell line. Fitoterapia73, 674–684. 10.1016/s0367-326x(02)00227-7
71
DanladiJ.AbdulsalamA.TimbuakJ. A.AhmedS. A.MairigaA. A.DahiruA. U. (2013). Hepatoprotective effect of black seed (nigella sativa) oil on carbon tetrachloride (CCl4) induced liver toxicity in adult wistar rats hepatoprotective effect of black seed (nigella sativa) oil on carbon tetrachloride (CCl 4) induced liver toxicity in. J. Dent. Med. Sci. (IOSR-JDMS)4, 56–62. 10.9790/0853-0435662
72
DeveliS.EvranB.KalazE. B.Koçak-tokerN.ErataG. Ö. (2014). Protective effect of Nigella sativa oil against binge ethanol-induced oxidative stress and liver injury in rats. Chin. J. Nat. Med.12, 495–499. 10.1016/S1875-5364(14)60077-7
73
DinakarA.SwarnalathaD.KumarR. P.AlekyaK.KumarS. P.KumarD. V.et al (2010). Inhibition of thioacetamide – induced liver fibrosis by piper nigrum linn. J. Glob. Trends Pharm. Sci.1, 1–8.
74
DirettoG.Rubio-MoragaA.ArgandoñaJ.CastilloP.Gómez-GómezL.AhrazemO. (2017). Tissue-specific accumulation of sulfur compounds and saponins in different parts of garlic cloves from purple and white ecotypes. Molecules22, 1359. 10.3390/molecules22081359
75
DoorikaP.AnanthiT. (2002). Antioxidant and hepatoprotective properties of Terminalia arjuna bark on isoniazed induced toxicity in albino rats. Asian J. Pharm. Technol.2, 15–18.
76
DuttaM.ChattopadhyayA.BoseG.GhoshA.BanerjeeA.GhoshA.et al (2014). Aqueous bark extract of Terminalia arjuna protects against high fat diet aggravated arsenic-induced oxidative stress in rat heart and liver, involvement of antioxidant mechanisms. J. Pharm. Res.8, 1285–1302.
77
EddouksM.AjebliM.HebiM. (2017). Ethnopharmacological survey of medicinal plants used in Daraa-Tafilalet region (Province of Errachidia), Morocco. J. Ethnopharmacol.198, 516–530. 10.1016/j.jep.2016.12.017
78
El HassaniM.DouiriE. M.BammiJ.ZidaneL.BadocA.DouiraA. (2013). Plantes médicinales de la Moyenne Moulouya (Nord-Est du Maroc). Ethnopharmacologia50, 39.
79
El-MesallamyA. M. D.Abdel-HamidN.SrourL.HusseinS. A. M. (2020). Identification of polyphenolic compounds and hepatoprotective activity of artichoke (Cynara scolymus L.) edible part extracts in rats. Egypt J. Chem.63, 2273–2285. 10.21608/ejchem.2020.22707.2348
80
El ShahatA. N.El-ShennawyH. M.Abd El-MegidM. H. M. (2017). Studying the protective effect of gamma-irradiated basil (Ocimum basilicum L.) against methotrexate-induced liver and renal toxicity in rats. Indian J. Anim. Res.51, 135–140. 10.18805/ijar.9631
81
ErisginZ.AtaseverM.CetinkayaK.ÖzenS.DizakarA.OmerogluS.et al (2019). Protective effects of Nigella sativa oil against carboplatin-induced liver damage in rats. Biomed. and Pharmacother.110, 742–747. 10.1016/j.biopha.2018.12.037
82
FakchichJ.ElachouriM. (2021). An overview on ethnobotanico-pharmacological studies carried out in Morocco, from 1991 to 2015: systematic review (part 1). J. Ethnopharmacol.267, 113200–200. 10.1016/j.jep.2020.113200
83
FanR.YuanF.WangN.GaoY.HuangY. (2015). Extraction and analysis of antioxidant compounds from the residues of Asparagus officinalis L. J. Food Sci. Technol.52, 2690–2700. 10.1007/s13197-014-1360-4
84
FarooquiZ.AfsarM.RizwanS.AhmedA.KhanF. (2016a). Oral administration of Nigella sativa oil ameliorates the effect of cisplatin on membrane enzymes, carbohydrate metabolism and oxidative damage in rat liver. Toxicol. Rep.3, 328–335. 10.1016/j.toxrep.2016.02.004
85
FarooquiZ.AfsarM.RizwanS.AhmedA.KhanF. (2016b). Oral administration of Nigella sativa oil ameliorates the effect of cisplatin on membrane enzymes, carbohydrate metabolism and oxidative damage in rat liver. Toxicol. Rep.3, 328–335. 10.1016/j.toxrep.2016.02.004
86
FennaneM. (2004). Propositions de zones importantes pour les plantes au Maroc (ZIP Maroc), 2–25.
87
FennaneM.Ibn TattouM.MathezJ.OuyahyaA.El OualidiJ. (1999). Flore Pratique du Maroc. Pteridophyta, Gymnospermae, Angiospermae (LauraceaeNeuradaceae) Man. détermination plantes vasculaires.Travaux l’Institut Sci. série Bot. n°36. Rabat1.
88
FennaneM.Ibn TattouM.OuyahyaA.El OualidiJ. (2007). Flore Pratique du Maroc. Angiospermae (Leguuminosae – Lentibulariaceae) Man. détermination plantes vasculaires.Travaux l’Institut Sci. série Bot. n°38. Rabat2.
89
FennaneM.Ibn TattouM.OuyahyaA.El OualidiJ. (2014). Manuel de Détermination des plantes vasculaires.Travaux de l’Institut Scientifique, série botanique n°40. Rabat. Dicotyledones (P.P), Monocotyledones3.
90
Fuentes-AlventosaJ. M.Jaramillo-CarmonaS.Rodríguez-GutiérrezG.Guillén-BejaranoR.Jiménez-AraujoA.Fernández-BolañosJ.et al (2013). Preparation of bioactive extracts from asparagus by-product. Food Bioprod. Process.91, 74–82. 10.1016/j.fbp.2012.12.004
91
GanaieM. A.KhanT. H.SiddiquiN. A.AnsariM. N. (2015). Ameliorative effect of methanol extract of Rumex vesicarius on CCl4-induced liver damage in Wistar albino rats. Pharm. Biol.53, 1163–1167. 10.3109/13880209.2014.967782
92
GasparyanG.TiratsuyanS.ShK.VardapetyanH. (2015). Effect of Laurus nobilis extract on the functioning of liver against Ccl4 induced toxicity. J. Exp. Biol. Agric. Sci.3, 174–183. 10.18006/2015.3(2).174.183
93
GebhardtR. (1998). Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (cynara scolymus L.) extracts. J. Pharmacol. Exp. Ther.286, 1122–1128.
94
Gholami-ahangaranM.RangsazN.AziziS. (2016). Evaluation of turmeric (Curcuma longa) effect on biochemical and pathological parameters of liver and kidney in chicken aflatoxicosis. Pharm. Biol.209, 780–787. 10.3109/13880209.2015.1080731
95
GhorbaniA.EsmaeilizadehM. (2017). Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med.7, 433–440. 10.1016/j.jtcme.2016.12.014
96
GhoshJ.DasJ.MannaP.SilP. C. (2010a). Protective effect of the fruits of Terminalia arjuna against cadmium-induced oxidant stress and hepatic cell injury via MAPK activation and mitochondria dependent pathway. Food Chem.123, 1062–1075. 10.1016/j.foodchem.2010.05.062
97
GhoshJ.DasJ.MannaP.SilP. C. (2010b). Protective effect of the fruits of Terminalia arjuna against cadmium-induced oxidant stress and hepatic cell injury via MAPK activation and mitochondria dependent pathway. Food Chem.123, 1062–1075. 10.1016/j.foodchem.2010.05.062
98
HachlafiN.ElBenkhairaN.FeriounM.KandsiF.JeddiM.ChebatA.et al (2022). Moroccan medicinal plants used to treat cancer: ethnomedicinal study and insights into pharmacological evidence. Evidence-Based Complementary Altern. Med.19. 10.1155/2022/1645265
99
HamzaR. Z.Al-harbiM. S. (2015). Amelioration of paracetamol hepatotoxicity and oxidative stress on mice liver with silymarin and Nigella sativa extract supplements. Asian Pac J. Trop. Biomed.5, 521–531. 10.1016/j.apjtb.2015.03.011
100
HarachT.AprikianO.MonnardI.MoulinJ.MembrezM.BéolorJ. C.et al (2010). Rosemary (Rosmarinus officinalis L.) Leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta Med.76, 566–571. 10.1055/s-0029-1240612
101
HoffmanB.GallaherT. (2007). Importance indices in ethnobotany. Ethnobot. Res. Appl.5, 201–218. 10.17348/era.5.0.201-218
102
HoshyarR.SebzariA.BalforoushM.ValaviM.HosseiniM. (2019). The impact of Crocus sativus stigma against methotrexate-induced liver toxicity in rats. J. ofComplementary IntegrativeMedicine13, 1–9. 10.1515/jcim-2019-0201
103
HsounaA. B.SaoudiM.TriguiM.JamoussiK.BoudawaraT.JaouaS.et al (2011). Characterization of bioactive compounds and ameliorative effects of Ceratonia siliqua leaf extract against CCl₄ induced hepatic oxidative damage and renal failure in rats. Food Chem. Toxicol.49, 3183–3191. 10.1016/j.fct.2011.09.034
104
HuseiniF. H.MahmoudabadyZ. M.ZiaiS. A.MehrazmaM.AlavianS. M.MehdizadehM.et al (2011). The effects of cynara scolymus L. Leaf and cichorium intybus L. Root extracts on carbon tetrachloride induced liver toxicity in rats fallah. J. Med. Plants10, 33–40.
105
HusnaM.SajjadS. (2017). The effect of crude nigella sativa oil against the acute toxicity of diclofenac sodium and ibuprofen on the liver of albino mice. Slov. Vet. Res.54, 20–27.
106
HussainM.TunioA. G.AkhtarL.ShaikhG. S. (2017). Effects of nigella sativa on various parameters in patients of non-alcoholic fatty liver disease. J. Ayub Med. Coll. Abbottabad29, 403–407.
107
International Society of Ethnobiology (2006). ISE Code of Ethics (with 2008 additions). J. Am. Med. Assoc.10.1001/jama.1893.02420400024007
108
IqbalM.ButtM.ShehzadA.AsgharM. (2018). Evaluating therapeutic potential of coriander seeds and leaves (Coriandrum sativum L.) to mitigate carbon tetrachloride-induced hepatotoxicity in rabbits. Asian Pac J. Trop. Med.11, 209–213. 10.4103/1995-7645.228435
109
JahandiezE.MaireR. (1931). Catalogue des plantes du Maroc. Minerva, Alger Lechevalier1.
110
JahandiezE.MaireR. (1932). Catalogue des plantes du Maroc. Minerva, Alger Lechevalier2.
111
JahandiezE.MaireR. (1934). Catalogue des plantes du Maroc. Minerva, Alger Lechevalier3.
112
JamilaF.MostafaE. (2014). Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments. J. Ethnopharmacol.154, 76–87. 10.1016/j.jep.2014.03.016
113
JangD. S.CuendetM.FongH. H. S.PezzutoJ. M.KinghornA. D. (2004). Constituents of Asparagus officinalis evaluated for inhibitory activity against cyclooxygenase-2. J. Agric. Food Chem.52, 2218–2222. 10.1021/jf0305229
114
JeburA. B.El-SayedR. A.El-DemerdashF. M. (2022). Ocimum basilicum essential oil modulates hematotoxicity, oxidative stress, DNA damage, and cell cycle arrest induced by β-cyfluthrin in rat liver. Front. Pharmacol.12, 784281–784314. 10.3389/fphar.2021.784281
115
JedidiS.AlouiF.SelmiS.SelmiH.SammariH.AyariA.et al (2022a). Antioxidant properties of Salvia officinalis decoction extract and mechanism of its protective effects on ethanol-induced liver and kidney injuries. J. Med. Food25, 546–556. 10.1089/jmf.2021.0134
116
JedidiS.AlouiF.SelmiS.SelmiH.SammariH.AyariA.et al (2022b). Antioxidant properties of Salvia officinalis decoction extract and mechanism of its protective effects on ethanol-induced liver and kidney injuries. J. Med. Food25, 546–556. 10.1089/jmf.2021.0134
117
JohriR. K. (2011). Cuminum cyminum and Carum carvi: an update. Pharmacogn. Rev.5, 63–72. 10.4103/0973-7847.79101
118
Juan-GarcíaA.AgahiF.DrakonakiM.TedeschiP.FontG.JuanC. (2021a). Cytoprotection assessment against mycotoxins on HepG2 cells by extracts from Allium sativum L. Food Chem. Toxicol.151, 112129. 10.1016/j.fct.2021.112129
119
Juan-GarcíaA.AgahiF.DrakonakiM.TedeschiP.FontG.JuanC. (2021b). Cytoprotection assessment against mycotoxins on HepG2 cells by extracts from Allium sativum L. Food Chem. Toxicol.151, 112129. 10.1016/j.fct.2021.112129
120
KadirM. F.Bin SayeedM. S.MiaM. M. K. (2013). Ethnopharmacological survey of medicinal plants used by traditional healers in Bangladesh for gastrointestinal disorders. J. Ethnopharmacol.147, 148–156. 10.1016/j.jep.2013.02.023
121
KannappanS. G. P.RaghunathG.SivanesanS.VijayaraghavanR. (2020). A study on the inhibition of oxidative stress, inflammation and apoptosis by Terminalia arjuna against acetaminophen-induced hepatotoxicity in wistar albino rats. Indian J. Biochem. Biophys.57, 51–57. 10.56042/ijbb.v57i1.26107
122
KanterM.CoskunO.BudancamanakM. (2005). Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J. Gastroenterology ISSN11, 6684–6688. 10.3748/wjg.v11.i42.6684
123
KhouchlaaA.TalbaouiA.El Yahyaoui El IdrissiA.BouyahyaA.Ait LahsenS.KahouadjiA.et al (2017a). Détermination des composés phénoliques et évaluation de l’activité litholytique in vitro sur la lithiase urinaire d’extrait de Zizyphus lotus L. d’origine marocaine. Phytotherapie, 1–6. 10.1007/s10298-017-1106-3
124
KhouchlaaA.TijaneM.ChebatA.HseiniS.KahouadjiA. (2017b). Ethnopharmacology study of medicinal plants used in the treatment of urolithiasis (Morocco). Phytotherapie15, 274–287. 10.1007/s10298-016-1073-4
125
KhoujaH. (2017). Turmeric (curcuma longa) protection against the liver toxicity caused by aluminum chloride (AlCl3) in adult male rats. Int. J. Pharm. Res. and Allied Sci.6, 110–127.
126
KimM. S.KoppulaS.SungS. J.LeeS. R.ParkY. D.LeeK. A.et al (2014). Olea europaea Linn (Oleaceae) fruit pulp exhibits hypocholesterolemic and hepatoprotective effects via regulation of peroxisome proliferation-activated receptor alpha in high-fat diet-fed rats. Trop. J. Pharm. Res.13, 31–39. 10.4314/tjpr.v13i1.5
127
KingsleyU. I. (2020). Ameliorative effect of hydroalcoholic extracts of Nigella sativa seed against CCl4-induced acute liver injury in rats. J. Drug Deliv. Ther.10, 164–169. 10.22270/jddt.v10i3.4006
128
KiokiasS.OreopoulouV. (2021). A review of the health protective effects of phenolic acids against a range of severe pathologic conditions (including coronavirus-based infections). Molecules26, 5405. 10.3390/molecules26175405
129
KoderaY.UshijimaM.AmanoH.SuzukiJ.MatsutomoT. (2017). Chemical and biological properties of S-1-propenyl-l-cysteine in aged garlic extract. Molecules22, 570. 10.3390/molecules22040570
130
KotokyJ.DasP. N. (2008). Medicinal plants used for liver diseases in some parts of Kamrup district of Assam, a North Eastern State of India. Fitoterapia79, 384–387. 10.1016/j.fitote.2008.02.003
131
KoubaaF. G.ChaâbaneM.TurkiM.AyadiF. M.El FekiA. (2021a). Antioxidant and hepatoprotective effects of Salvia officinalis essential oil against vanadium-induced oxidative stress and histological changes in the rat liver. Environ. Sci. Pollut. Res.28, 11001–11015. 10.1007/s11356-020-11303-z
132
KoubaaF. G.ChaâbaneM.TurkiM.AyadiF. M.El FekiA. (2021b). Antioxidant and hepatoprotective effects of Salvia officinalis essential oil against vanadium-induced oxidative stress and histological changes in the rat liver. Environ. Sci. Pollut. Res.28, 11001–11015. 10.1007/s11356-020-11303-z
133
Koubaa-GhorbelF.ChaâbaneM.TurkiM.Makni-AyadiF.El FekiA. (2020a). The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet. J. Food Biochem.44, 131600–e132. 10.1111/jfbc.13160
134
Koubaa-GhorbelF.ChaâbaneM.TurkiM.Makni-AyadiF.El FekiA. (2020b). The protective effects of Salvia officinalis essential oil compared to simvastatin against hyperlipidemia, liver, and kidney injuries in mice submitted to a high-fat diet. J. Food Biochem.44, 131600–e132. 10.1111/jfbc.13160
135
KozicsK.KlusováV.SrančíkováA.MučajiP.SlameňováD.HunákováĽ.et al (2013a). Effects of Salvia officinalis and Thymus vulgaris on oxidant-induced DNA damage and antioxidant status in HepG2 cells. Food Chem.141, 2198–2206. 10.1016/j.foodchem.2013.04.089
136
KozicsK.KlusováV.SrančíkováA.MučajiP.SlameňováD.HunákováĽ.et al (2013b). Effects of Salvia officinalis and Thymus vulgaris on oxidant-induced DNA damage and antioxidant status in HepG2 cells. Food Chem.141, 2198–2206. 10.1016/j.foodchem.2013.04.089
137
KpodarM. S.KarouS. D.KatawaG.AnaniK.GbekleyH. E.AdjrahY.et al (2016). An ethnobotanical study of plants used to treat liver diseases in the Maritime region of Togo. J. Ethnopharmacol.181, 263–273. 10.1016/j.jep.2015.12.051
138
LabiadH.Et-tahirA.GhanmiM.SatraniB.AljaiyashA.ChaouchA.et al (2020). Ethnopharmacological survey of aromatic and medicinal plants of the pharmacopoeia of northern Morocco. Ethnobot. Res. Appl.19, 1–16. 10.32859/era.19.45.1-16
139
LaylaniL. A.-A.-S. S. (2016). Hepatoprotective effect of Glycyrrhiza glabra L. Extracts against carbon tetrachloride-induced acute liver damage in rats. Int. J. Veterinary Sci. Med. and Res.1, 1–8.
140
LinC. C.HuangP. C. (2000). Antioxidant and hepatoprotective effects of Acathopanax senticosus. Phytotherapy Res.14, 489–494. 10.1002/1099-1573(200011)14:7<489::AID-PTR656>3.0.CO;2-G
141
LöhrG.DetersA.HenselA. (2009). In vitro investigations of Cynara scolymus L. extract on cell physiology of HepG2 liver cells. Braz. J. Pharm. Sci.45, 201–208. 10.1590/s1984-82502009000200003
142
LuY.FooL. Y. (2002). Polyphenolics of salvia—a review. Phytochemistry59, 117–140. 10.1016/s0031-9422(01)00415-0
143
LucariniR.BernardesW. A.TozattiM. G.FilhoA. A. da S.SilvaM. L. A.MomoC.et al (2014). Hepatoprotective effect of Rosmarinus officinalis and rosmarinic acid on acetaminophen-induced liver damage. Emir J. Food Agric.26, 878–884. 10.9755/ejfa.v26i10.17836
144
MaameriZ.DjerrouZ.HalmiS.DjaalabH.RiachiF.HamdipachaY. (2015). Evaluation of hepatoprotective effect of Pistacia lentiscus L. Fatty oil in rats intoxicated by carbon tetrachloride. Int. J. Pharmacogn. Phytochemical Res.7, 251–254.
145
MahdiS.TurfiA.MohammedA.Chasib JabalB. (2022). Evaluation of the effect of alcoholic extract of Laurus nobilis leaves on blood biochemical parameters and histological changes in the liver and kidney among female wistar rats treated with depakene (sodium valproate). Arch. Razi Inst.77, 981–989. 10.22092/ARI.2022.357272.2011
146
MahmoudM. R.El-abharH. S.SalehS. (2002). The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J. Ethnopharmacol.79, 1–11. 10.1016/s0378-8741(01)00310-5
147
MallhiT. H.AbbasK.AliM.QadirM. I.SaleemM.KhanY. H. (2014). Hepatoprotective activity of methanolic extract of Malva parviflora against paracetamol-induced hepatotoxicity in mice. Bangladesh J. Pharmacol.9, 342–346. 10.3329/bjp.v9i3.19105
148
MannaP.SinhaM.SilP. C. (2006). Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complement. Altern. Med.6, 33–10. 10.1186/1472-6882-6-33
149
MansinghD. P.DalpatiN.SaliV. K.VasanthiA. H. R. (2018). Alliin the precursor of allicin in garlic extract mitigates proliferation of gastric adenocarcinoma cells by modulating apoptosis. Pharmacogn. Mag.14, 84. 10.4103/pm.pm_342_17
150
MarcellinP.KutalaB. K. (2018). Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int.38, 2–6. 10.1111/liv.13682
151
MarmouziI.KharbachM.El JemliM.BouyahyaA.CherrahY.BouklouzeA.et al (2019). Antidiabetic, dermatoprotective, antioxidant and chemical functionalities in Zizyphus lotus leaves and fruits. Ind. Crops Prod.132, 134–139. 10.1016/j.indcrop.2019.02.007
152
MeeraR.DeviP.KameswariB.MadhumithaB.MerlinN. J. (2009). Antioxidant and hepatoprotective activities of ocimum basilicum linn. And trigonella foenum-graecum linn. against H2O2 and CCl 4 induced hepatotoxicity in goat liver. Indian J. Exp. Biol.47, 584–590.
153
MiccadeiS.VenereD.DiCardinaliA.RomanoF.DurazzoA.FoddaiM. S.et al (2008). Antioxidative and apoptotic properties of polyphenolic extracts from edible part of artichoke (Cynara scolymus L.) on cultured rat hepatocytes and on human hepatoma cells. Nutr. Cancer60, 276–283. 10.1080/01635580801891583
154
MohajeriD.AbbasiM. M.DelazarA.DoustarY.NouriM. H. K. (2007). Subacute toxicity of crocus sativus L. (Saffron) stigma ethanolic extract in rats. Am. J. Pharmacol. Toxicol.2 (2), 189–193. 10.3844/ajptsp.2007.189.193
155
MohamedH. A.El-SayedI. H.MoawadM. (2011). Protective effect of nigella sativa seeds against dimethylaminoazobenzene (dab) induced liver carcinogenesis. Cancer Biol.1, 13–19.
156
MohammadianA.MoradkhaniS.AtaeiS.ShayestehT. H.SedaghatM.KheiripourN.et al (2016). Antioxidative and hepatoprotective effects of hydroalcoholic extract of Artemisia absinthium L. in rat. J. HerbMed Pharmacol.5, 29–32.
157
MohammedH. H.RabehN. M.HaggagM. H. (2020). Efficacy of coconut oil (Cocos nucifera L.) fortification on liver functions rats with induced hypothyroidism. Curr. Sci. Int.9, 240–250. 10.36632/csi/2020.9.2.20
158
MokraneN.OmarK.FatimaZ. T.AkilaG.AbdelkaderA. (2020). The effect of Thymus vulgaris L. on renal and liver toxicity in wistar rats exposed to aluminum. J. Med. Plants Res.14, 13–23. 10.5897/jmpr2019.6819
159
MostafaM. E. A.Al-AmriM.KamelA. M. F. (2018). Hepatoprotective potential of Rumex vesicarius against malathion hepatotoxicity in adult albino rats. Eur. J. Anat.22, 449–459.
160
MushtaqA.AslamB.MuhammadF.KhanJ. A. (2021). Hepatoprotective activity of nigella sativa and piper nigrum against concanavalin a-induced acute liver injury in mouse model. Pak Vet. J.41, 78–84. 10.29261/pakvetj/2020.076
161
NajemM.IbijbijenJ.NassiriL. (2019). Quantitative ethnobotanical study of poisonous medicinal plants used in the traditional pharmacopoeia of the central middle atlas region: Morocco. Ethnobot. Res. Appl.18, 1–17. 10.32859/era.18.36.1-17
162
NeharS.KumariM. (2013). Ameliorating effect of nigella sativa oil in thioacetamide-induced liver cirrhosis in albino rats. Indian J. Pharm. Educ. Res.47, 135–139.
163
NenciniC.FranchiG. G.CavalloF.MicheliL. (2010). Protective effect of Allium neapolitanum Cyr. versus Allium sativum L. on acute ethanol-induced oxidative stress in rat liver. J. Med. Food13, 329–335. 10.1089/jmf.2008.0180
164
NoureddineB.MostafaE.MandalS. C. (2022). Ethnobotanical, pharmacological, phytochemical, and clinical investigations on Moroccan medicinal plants traditionally used for the management of renal dysfunctions. J. Ethnopharmacol.292, 115178. 10.1016/j.jep.2022.115178
165
NutritionA.Medi-V.NutritionA.Medi-V. (2017). The effect of thyme essential oil (thymus vulgaris) added to quail diets on performance, some blood parameters, and the antioxidative metabolism of the serum and liver tissues. Braz. hournal Poult. Sci.19, 297–304. 10.1590/1806-9061-2016-0403
166
NwozoS. O.OsunmadewaD. A.OyinloyeB. E. (2014). Anti-fatty liver effects of oils from Zingiber officinale and Curcuma longa on ethanol-induced fatty liver in rats. J. Integr. Med.12, 59–65. 10.1016/S2095-4964(14)60006-6
167
OmarT. Y.OmarT. Y. (2014). Protective efficacy of Glycyrrhiza glabra on Ccl4 induced liver injury in rabbits. World J. Pharm. Res.3, 3627–3638.
168
OmidiA.RiahiniaN.BagherM.TorbatiM. (2014). Hepatoprotective effect of Crocus sativus (saffron) petals extract against acetaminophen toxicity in male Wistar rats. Avicenna J. Phytomed4, 330–336.
169
OsmanN. N.GhazwaniA. H.BalamashK. S. (2020). Evaluation of the effect of gamma-irradiated basil (ocimum basilicum L.) on liver toxicity induced by arsenic in rats. J. Radiat. Res. Appl. Sci.13, 552–559. 10.1080/16878507.2020.1777656
170
OuahhoudS.TouissI.KhoulatiA.LahmassI.MamriS.MezianeM.et al (2021a). Hepatoprotective effects of hydroethanolic extracts of Crocus sativus tepals, stigmas and leaves on carbon tetrachloride induced acute liver injury in rats. Physiology Pharmacol.25, 178–188. 10.32598/ppj.25.2.30
171
OuahhoudS.TouissI.KhoulatiA.LahmassI.MamriS.MezianeM.et al (2021b). Hepatoprotective effects of hydroethanolic extracts of Crocus sativus tepals, stigmas and leaves on carbon tetrachloride induced acute liver injury in rats. Physiology Pharmacol.25, 178–188. 10.32598/ppj.25.2.30
172
PaS.MyP.VtT.TrG. (2010). Protective effect of hordeum vulgare linn. on acetaminophen- induced liver damage. Pharmacology1, 336–340. 10.4103/0975-1483.59324
173
PanezaiA. J.KhanM.IshaqueS. M.UllahR.KhanA. A.RahatN. (2022). Variable doses of Nigella sativa in isoniazid induced liver toxicity in rabbits. Pak Euro J. Med. Life Sci.5 (2), 187–194. 10.31580/pjmls.v5i2.2405
174
ParsaiA.EidiM.SadeghipourA. (2015). Hepatoprotective effect of sage (Salvia officinalis L.) leaves hydro-methanolic extract against Aspergillus parasiticus aflatoxin-induced liver damage in male rats. 4th Natl. Congr. Med. Plants12, 704.
175
PereiraR.JacociunasL. V.DeR. F.ReginaB.AbreuR.DeLehmannM.et al (2017). Genotoxic and chemopreventive assessment of Cynara scolymus L. aqueous extract in a human-derived liver cell line aqueous extract in a human-derived liver cell line. Drug Chem. Toxicol.0545, 1525–6014. 10.1080/01480545.2017.1279625
176
PrajapatiH. A.VermaR. J. (2022). Protective effect of Nigella sativa against diethyl phthalate-induced changes in mitochondrial enzymatic activities in liver of mice. J. Sci. Healthc. Explor.4, 6–10. 10.2019/JSHE/202206002
177
PrasadR.AliS.KhanL. A. (2010). Hepatoprotective effect of Syzygium aromaticum extract on acute liver injury induced by thioacetamide. Int. J. Pharm. Clin. Res.2, 68–71.
178
RadwanR. R.MohamedH. A. (2018). Nigella sativa oil modulates the therapeutic efficacy of mesenchymal stem cells against liver injury in irradiated rats. J. Photochem Photobiol.178, 447–456. 10.1016/j.jphotobiol.2017.11.037
179
RatsL.BeheshtiF.NorouziF.AbareshiA.KhazaeiM.AlikhaniV.et al (2018). Nigella sativa prevented liver and renal tissue damage in lipopolysaccharide-treated rats. Saudi J. Kidney Dis. Transplant.29, 554–566. 10.4103/1319-2442.235184
180
RavindranC. A.MurugaiyahV. A. L.KhiangP. E. H. K. O. K. (2013). Hepatoprotective activity of leaf of methanol extract of Laurus nobilis.L against paracetamol induced hepatotoxicity in rats. Asian J. Pharm. Clin. Res.6, 7–11.
181
RGPH (2014). Recensement Général de la Population et de l’Habitat.
182
RiazH.SaleemN.AhmadM.MehmoodY. (2016). Hepatoprotective effect of crocus sativus on amiodarone-induced liver toxicity hepatoprotective effect of crocus sativus on amiodarone-induced liver toxicity. Br. J. Pharm. Res.12, 1–11. 10.9734/BJPR/2016/27219
183
RinderO.AnimalP.MpG. (2011). Pandey Govind2, 115–121.
184
RobyM. H. H.SarhanM. A.SelimK. A.-H.KhalelK. I. (2013). Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Ind. Crops Prod.43, 827–831. 10.1016/j.indcrop.2012.08.029
185
RtibiK.SelmiS.JabriM. A.El-BennaJ.AmriM.MarzoukiL.et al (2016). Protective effect of ceratonia siliqua L. Against a dextran sulfate sodium-induced alterations in liver and kidney in rat. J. Med. Food19, 882–889. 10.1089/jmf.2016.0020
186
SadeghiH.AzarmehrN.MansourianM.KhalvatiB.KokhdanE. P.SalehpourZ.et al (2020). The hydroalcoholic extract of Rosmarinus officinalis attenuates liver damage after bile-duct ligation in rats. J. Anim. Plant Sci.31, 432–440. 10.36899/JAPS.2021.2.0232
187
SairaK.FaizaN.ImranS.SarmadI.FaizaA.SanaS.et al (2020). Hepatoprotective role of fruit extract of Terminalia arjuna in acetaminophen intoxicated mice. Adv. Life Sci.8, 63–67.
188
SalamaS. M.AbdullaM. A.AlrashdiA. S.IsmailS.AlkiyumiS. S.GolbabapourS. (2013). Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. BMC Complement. Altern. Med.13, 56–17. 10.1186/1472-6882-13-56
189
SalahshoorM. R.RoshankhahS.JaliliC. (2019). Antioxidative Properties of Thymus vulgaris on Liver Rats Induced by Paclitaxel. Pharmacogn. Res.11. 10.4103/pr.pr_45_19
190
SalemA. M.MahdyK. A.HassanN. S.El-saeedG. S. M.RazikA.FarragH.et al (2017). Nigella sativa seed reduced galectin-3 level and liver fibrosis in thioacetamide-induced liver injury in rats. J. Arab Soc. Med. Res.12, 46–55. 10.4103/jasmr.jasmr_8_17
191
SalemM. B.KsoudaK.DhouibiR.CharfiS.TurkiM.HammamiS.et al (2019). LC-MS/MS analysis and hepatoprotective activity of artichoke (cynara scolymus L.) leaves extract against high fat diet-induced obesity in rats. Biomed. Res. Int.12. 10.1155/2019/4851279
192
SamarghandianS.Asadi-samaniM.FarkhondehT. (2016). Assessment the effect of saffron ethanolic extract (Crocus sativus L.) on oxidative damages in aged male rat liver. Scholars Res. Libr. Der8, 283–290.
193
SamojlikI.LakicN.Mimica-DukicN.Akovic-SvajcerK.BozinB. (2010). Antioxidant and hepatoprotective potential of essential oils of coriander (coriandrum sativum L.) and caraway (carum carvi L.) (Apiaceae). Agric. Food Chem.58, 8848–8853. 10.1021/jf101645n
194
SangamithiraS. P.RevathyJ.Sheik AbdullahS.Sampath KumarP. (2011). The hepatoprotective effect of ethanolic bark extract of Terminalia arjuna on paracetamol induced liver damage. Biosci. Biotechnol. Res. Asia8, 777–781. 10.13005/bbra/934
195
SarginS. A.SelviS.BüyükcengizM. (2015). Ethnomedicinal plants of aydincik district of mersin, Turkey. J. Ethnopharmacol.174, 200–216. 10.1016/j.jep.2015.08.008
196
SasakiK.WadaK.TanakaY.YoshimuraT.MatuokaK.AnnoT. (2005). Thyme (Thymus vulgaris L.) leaves and its constituents increase the activities of xenobiotic-metabolizing enzymes in mouse liver. J. Med. Food8, 184–189. 10.1089/jmf.2005.8.184
197
SavoV.CanevaG.MariaG. P.DavidR. (2011). Folk phytotherapy of the amalfi coast (campania, southern Italy). J. Ethnopharmacol.135, 376–392. 10.1016/j.jep.2011.03.027
198
ShahP. V.ParmarM.ThakkarV.TejalG. (2009). Hepatoprotective activity of Hordeum Vulgare linn. Seeds against ethanol-induced liver damage in rats. Pharmacologyonline2, 538–545.
199
ShahrzadK.MahyaN.FatemehT. B.MaryamK.MohammadrezaF. B.JahromyM. H. (2014a). Hepatoprotective and antioxidant effects of Salvia officinalis L. Hydroalcoholic extract in male rats. Chin. Med.05, 130–136. 10.4236/cm.2014.52016
200
ShahrzadK.MahyaN.FatemehT. B.MaryamK.MohammadrezaF. B.JahromyM. H. (2014b). Hepatoprotective and antioxidant effects of Salvia officinalis L. Hydroalcoholic extract in male rats. Chin. Med.05, 130–136. 10.4236/cm.2014.52016
201
Shalizar-jalaliA.HasanzadehS.KarimiA. (2013). Crataegus monogyna fruit aqueous extract as an attenuator of doxorubicin-induced hepatotoxicity in rat model. Toxicology2013, 15–17.
202
SharmaV.AgrawalR. (2014). In vivo antioxidant and hepatoprotective potential of Glycyrrhiza glabra extract on carbon tetra chloride (CCl4) induced oxidative-stress mediated hepatotoxicity. Int. J. Res. Med. Sci.2, 314. 10.5455/2320-6012.ijrms20140260
203
ShindeD. B.KoratkarS.ShitoleA. (2016). Antioxidant activity and antiproliferative action of methanolic extract of liquorice (Glycyrrhiza glabra) in Hepg2 cell line. Int. J. Pharm. Pharm. Sci.8, 293–298. 10.22159/ijpps.2016v8i9.11954
204
ShivananjappaM. M.JoshiM. K. (2012). Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2). Pharm. Biol.50, 497–505. 10.3109/13880209.2011.618501
205
ShivananjappaM. M.MhasavadeD.JoshiM. K. (2013). Aqueous extract of Terminalia arjuna attenuates tert-butyl hydroperoxide-induced oxidative stress in HepG2 cell model. Cell. Biochem. Funct.31, 129–135. 10.1002/cbf.2867
206
SivalokanathanS.VijayababuM. R.BalasubramanianM. P. (2006). Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J. Gastroenterol.12, 1018–1024. 10.3748/wjg.v12.i7.1018
207
SlatnarA.PetkovsekM. M.StamparF.VebericR.HorvatJ.JakseM.et al (2018). Game of tones: sugars, organic acids, and phenolics in green and purple asparagus (Asparagus officinalis L.) cultivars. Turkish J. Agric. For.42, 55–66. 10.3906/tar-1707-44
208
SnehaK.ReddyA. G.RaniM. U.RamyaB.KumarP. S.KumarB. A. (2021). Evaluation of Terminalia arjuna in comparison to taurine against experimental nephrotoxicity due to cisplatin in rats. Indian J. Anim. Res.11, 367–373. 10.18805/ijar.b-4466
209
SolanaM.BoschieroI.Dall’AcquaS.BertuccoA. (2015). A comparison between supercritical fluid and pressurized liquid extraction methods for obtaining phenolic compounds from Asparagus officinalis L. J. Supercrit. Fluids100, 201–208. 10.1016/j.supflu.2015.02.014
210
SreekeesoonD. P.MahomoodallyM. F. (2014). Ethnopharmacological analysis of medicinal plants and animals used in the treatment and management of pain in Mauritius. J. Ethnopharmacol.157, 181–200. 10.1016/j.jep.2014.09.030
211
SunT.PowersJ. R.TangJ. (2007). Evaluation of the antioxidant activity of asparagus, broccoli and their juices. Food Chem.105, 101–106. 10.1016/j.foodchem.2007.03.048
212
TabutiJ. R. S.DhillionS. S.LyeK. A. (2003). Traditional medicine in Bulamogi county, Uganda: its practitioners, users and viability. J. Ethnopharmacol.85, 119–129. 10.1016/S0378-8741(02)00378-1
213
TajuaG.MajeedaS. A.NambiaK. S. N.JayanthibM. (2011). Hepatoprotective and antioxidant effects of Glycyrrhiza glabra extract against paracetamol induced liver damage in rats. J. Pharm. Res.4, 3798–3802.
214
TanbekK.OzerolE.BilgicS.IrazM.SahinN.ColakC. (2017). Protective effect of Nigella sativa oil against thioacetamide-induced liver injury in rats. Med. Sci. | Int. Med. J.6, 1–103. 10.5455/medscience.2016.05.8531
215
TemizM. A.TemurA.Çelikİ. (2015). Antioxidant role and hepatoprotective effects of carob (ceratonia siliqua L.) seeds against ethanol-induced oxidative stress in rats. J. Food Nutr. Res.3, 57–61. 10.12691/jfnr-3-1-10
216
ThomsonM.AliM. (2003). Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr. Cancer Drug Targets3, 67–81. 10.2174/1568009033333736
217
TuZ.Moss-PierceT.FordP.JiangT. A. (2013). Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 cells. J. Agric. Food Chem.61, 2803–2810. 10.1021/jf400298c
218
UchioR.HigashiY.KohamaY.KawasakiK.HiraoT.MurosakiK. M. S.et al (2017). A hot water extract of turmeric (Curcuma longa) suppresses acute ethanol-induced liver injury in mice by inhibiting hepatic oxidative stress and inflammatory cytokine production. J. Nutr. Sci.6, e3–e9. 10.1017/jns.2016.43
219
UsiaS. T.KadotaS.TezukaY. (2005). Alkamides from piper nigrum L. And their inhibitory activity against human liver microsomal cytochrome P450 2D6 (CYP2D6). Nat. Prod. Commun.1, 1–7. 10.1055/s-2006-931558
220
UstunerD.ColakE.DincerM.TekinN.Burukoglu DonmezD.AkyuzF.et al (2018). Posttreatment effects of olea europaea L. Leaf extract on carbon tetrachloride-induced liver injury and oxidative stress in rats. J. Med. Food21, 899–904. 10.1089/jmf.2017.0143
221
VargheseA.SavaiJ.PanditaN.GaudR. (2015). In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes. Toxicol. Rep.2, 806–816. 10.1016/j.toxrep.2015.02.008
222
Venmathi MaranB. A.IqbalM.GangadaranP.AhnB.-C.RaoP. V.ShahM. D. (2022). Hepatoprotective potential of Malaysian medicinal plants: a review on phytochemicals, oxidative stress, and antioxidant mechanisms. Molecules27, 1533. 10.3390/molecules27051533
223
VidičevićS.TošićJ.StanojevićŽ.IsakovićA.MitićD.RistićD.et al (2020). Standardized Olea europaea L. leaf extract exhibits protective activity in carbon tetrachloride-induced acute liver injury in rats: the insight into potential mechanisms. Arch. Physiol. Biochem.126, 399–407. 10.1080/13813455.2018.1550095
224
WeiC.QiuJ.WuY.ChenZ.YuZ.HuangZ.et al (2022). Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis). J. Ethnopharmacol.297, 115550. 10.1016/j.jep.2022.115550
225
WeiX.XiaL.ZiyayidingD.ChenQ.LiuR.XuX.et al (2019). The Extracts of Artemisia absinthium L. Suppress the growth of hepatocellular carcinoma cells through induction of apoptosis via endoplasmic reticulum stress and mitochondrial-dependent pathway. Molecules24, 913–917. 10.3390/molecules24050913
226
YacoutG.NihalM. E.EmanF. E. A. (2012). Hepatoprotective effect of basil (Ocimum basilicum L.) on CCl4-induced liver fibrosis in rats. Afr. J. Biotechnol.11, 15702–15711. 10.5897/ajb12.2048
227
YinG.FisheriesF.JeneyG.HingaryS.NakaoM.LuC. (2011). Hepatoprotective and antioxidant effects of Glycyrrhiza glabra extract against carbon tetrachloride (CCl4)-induced hepatocyte damage in common carp (Cyprinus carpio). Fish. Physiol. Biochem.37, 209–216. 10.1007/s10695-010-9436-1
228
YooD. Y.KimW.NamS. M.YooM.LeeS.YoonY. S.et al (2014a). Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia. Food Chem. Toxicol.72, 1–7. 10.1016/j.fct.2014.06.023
229
YooM.LeeS.KimS.HwangJ.-B.ChoeJ.ShinD. (2014b). Composition of organosulfur compounds from cool-and warm-type garlic (Allium sativum L.) in Korea. Food Sci. Biotechnol.23, 337–344. 10.1007/s10068-014-0047-y
230
YoudimK. A.DeansS. G. (1999). Dietary supplementation of thyme (Thymus vulgaris L.) essential oil during the lifetime of the rat: its effects on the antioxidant status in liver, kidney and heart tissues. Mech. Ageing Dev.109, 163–175. 10.1016/S0047-6374(99)00033-0
231
ZhangC.ZhaoJ.FamousE.PanS.PengX.TianJ. (2021). Antioxidant, hepatoprotective and antifungal activities of black pepper (Piper nigrum L.) essential oil. Food Chem.346, 128845. 10.1016/j.foodchem.2020.128845
232
ZhuX.ZhangW.ZhaoJ.WangJ.QuW. (2010). Hypolipidemic and hepatoprotective effects of ethanolic and aqueous extracts from Asparagus officinalis L. by-products in mice fed a high-fat diet. J. Sci. Food Agric.90, 1129–1135. 10.1002/jsfa.3923
Summary
Keywords
ethnobotany, ethnopharmacology, traditional medicine, medicinal plants, liver diseases
Citation
Bencheikh N, Elbouzidi A, Baraich A, Bouhrim M, Azeroual A, Addi M, Mothana RA, Al-Yousef HM, Eto B and Elachouri M (2024) Ethnobotanical survey and scientific validation of liver-healing plants in northeastern Morocco. Front. Pharmacol. 15:1414190. doi: 10.3389/fphar.2024.1414190
Received
08 April 2024
Accepted
26 August 2024
Published
10 September 2024
Volume
15 - 2024
Edited by
Da-Cheng Hao, Dalian Jiaotong University, China
Reviewed by
Nilufer ORHAN, Independent Researcher, Austin, United States
Shibani Mohapatra, Siksha “O” Anusandhan University, India
Weka Sidha Bhagawan, University of PGRI Madiun, Indonesia
Updates
Copyright
© 2024 Bencheikh, Elbouzidi, Baraich, Bouhrim, Azeroual, Addi, Mothana, Al-Yousef, Eto and Elachouri.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amine Elbouzidi, amine.elbouzidi@ump.ac.ma; Noureddine Bencheikh, bencheikh_noureddine1718@ump.ac.ma; Mohamed Bouhrim, mohamed.bouhrim@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.